Logo Université Laval Logo Université Laval Logo Université Laval

Découvrez nos professeurs et professeures!

Paul R. Fortin

Médecin clinicien enseignant titulaire

Paul R. Fortin
Centre de recherche du CHU de Québec - Université Laval
Partager la fiche :
Ce profil n’a pas encore été complété.

Contribution à la recherche

Projets de recherche

  • Canada research chair in Innovate Systemic Autoimmune Rheumatic Disease - Instituts de recherche en santé du Canada - Chaires de recherche du Canada - Fonctionnement, chercheur principal - 2019-07-01 au 2026-06-30
  • Centre de recherche en arthrite (ARThrite) - Université Laval - Fonds internes - BDR - Centres de recherche reconnus, chercheur principal - 2020-11-03 au 2026-04-30
  • Fonds institutionnel d'exploitation des infrastructures pour l'Université Laval - Fondation Canadienne pour l'innovation (La) - Fonds d'exploitation des infrastructures (FEI), co-chercheur - 2002-04-01 au 2025-03-31
  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis - Instituts de recherche en santé du Canada - Subvention Projet, co-chercheur - 2020-04-01 au 2025-03-31
  • The impact of antimalarial drugs in arthritis patients exposed to SARS-CoV-2- the CoVIRAL project - La société d'arthrite, chercheur principal - 2020-04-01 au 2023-03-31
  • Hydroxychloroquine in systemic lupus - Instituts de recherche en santé du Canada - Subvention Projet, McGill University, co-chercheur - 2018-04-01 au 2023-03-31
  • Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis - La société d'arthrite, co-chercheur - 2020-01-01 au 2022-12-31
  • Mapping anti-mitochondrial antibodies in systemic lupus erythematosus - Instituts de recherche en santé du Canada - Subvention Projet, chercheur principal - 2019-04-01 au 2022-03-31
  • Unité support du Québec: Un soutien pour la recherche axée sur le patient. - Fonds de recherche du Québec - Santé, Instituts de recherche en santé du Canada - Unités de soutien de la stratégie de recherche axée sur le patient(SRAP), Université de Sherbrooke, co-chercheur - 2014-04-01 au 2022-03-31
  • Projet de recherche sur les maladies arthritiques - Fondation de l'Université Laval, chercheur principal - 2019-12-01 au 2021-11-30
  • New statistical methods for cohort studies of adverse effects of medications - Instituts de recherche en santé du Canada - Subvention Projet, McGill University, co-chercheur - 2016-07-01 au 2021-06-30
  • Role of autotaxin bound to platelet-derived microparticles to development of vascular damage in arthritis. - Instituts de recherche en santé du Canada - Subvention de fonctionnement, co-chercheur - 2015-07-01 au 2021-06-30
  • Maladies Rhumatismales Autoimmunes Systémiques (MRAS) - Fondation du CHU de Québec, chercheur principal - 2020-12-15 au 2021-03-31
  • Understanding the pathogenesis of COVID-19 - Instituts de recherche en santé du Canada, Secrétariat Inter-Conseils (Canada) (CRSH, CRSNG, IRSC) - Subvention de fonctionnement : Possibilité de financement canadienne pour une intervention de recherche rapide contre la maladie à coronavirus 2019 (COVID-19), co-chercheur - 2020-03-01 au 2021-02-28
  • MyArthritisGuide for rheumatoid arthritis will improve patient's activation towards self-care - Société canadienne de rhumatologie, chercheur principal - 2018-07-01 au 2020-06-30
  • Platelets and their microparticles: versatile players of inflammation. - Instituts de recherche en santé du Canada - Subventions Fondation, co-chercheur - 2015-07-01 au 2020-06-30
  • Projet de recherche sur les maladies rhumatismales auto-immunes systémiques - Fondation du CHU de Québec, chercheur principal - 2019-07-18 au 2020-03-31
  • Financement de projet de recherche clinique en rhumatologie - Fondation du CHU de Québec, chercheur principal - 2020-01-06 au 2020-03-31
  • Support informatique (navigateur interactif en ligne) pour les patients souffrant d'arthrite rhumatoïde - Fondation du CHU de Québec, chercheur principal - 2019-05-14 au 2020-03-31
  • Centre de recherche en arthrite de l'Université Laval - Université Laval - Fonds internes - BDR - Entités de recherche en émergence, chercheur principal - 2019-01-01 au 2020-01-31
  • Canadian Network for Advanced interdisciplinary Methods for Prospective Studies of Drug Safety and Effectiveness - Instituts de recherche en santé du Canada - Subvention d'équipe : Centre de collaboration pour les études prospectives du RIEM, McGill University, co-chercheur - 2014-09-01 au 2019-08-31

Publications

  • Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study, Wu, Y., Kwakkenbos, L., Henry, R.S., Carrier, M.-E., Gagarine, M., Harb, S., Bourgeault, A., Tao, L., Carboni-Jiménez, A., Negeri, Z., Patten, S., Bartlett, S.J., Mouthon, L., Varga, J., Benedetti, A., Thombs, B.D., Fortuné, C., Gietzen, A., Guillot, G., Lewis, N., Richard, M., Sauvé, M., Welling, J., Fligelstone, K., Gottesman, K., Leite, C., Pérez, E., Baron, M., Malcarne, V., Mayes, M.D., Nielson, W.R., Riggs, R., Assassi, S., Ells, C., van den Ende, C., Frech, T., Harel, D., Hinchcliff, M., Hudson, M., Johnson, S.R., Larche, M., Nguyen, C., Pope, J., Rannou, F., Reyna, T.S.R., Schouffoer, A.A., Suarez-Almazor, M.E., Agard, C., Albert, A., Bernstein, E.J., Berthier, S., Bissonnette, L., Bruns, A., Carreira, P., Chaigne, B., Chung, L., Correia, C., Denton, C., Domsic, R., Dunne, J.V., Dunogue, B., Farge-Bancel, D., Fortin, P.R., Gordon, J., Granel-Rey, B., Hatron, P.-Y., Herrick, A.L., Hoa, S., Jones, N., Fernandes, A.J.D.B., Kafaja, S., Khalidi, N., Launay, D., Manning, J., Marie, I., Martin, M., Mekinian, A., Melchor, S., Nikpour, M., Olagne, L., Proudman, S., Régent, A., Rivière, S., Robinson, D., Rodriguez, E., Roux, S., Sobanski, V., Steen, V., Sutton, E., Thorne, C., Wilcox, P., Ayala, M.C., Nordlund, J., Østbø, N., Rice, D.B., Turner, K.A., Culos-Reed, N., Dyas, L., El-Baalbaki, G., Hebblethwaite, S., Bustamante, L., Duchek, D., Ellis, K., Journal of Psychosomatic Research, 2021, 10.1016/j.jpsychores.2020.110314
  • Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort, Urowitz, M.B., Gladman, D.D., Farewell, V., Su, J., Romero-Diaz, J., Bae, S.-C., Fortin, P.R., Sanchez-Guerrero, J., Clarke, A.E., Bernatsky, S., Gordon, C., Hanly, J.G., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Ginzler, E., Alarcón, G.S., Chatham, W.W., Petri, M.A., Bruce, I.N., Khamashta, M.A., Aranow, C., Dooley, M.A., Manzi, S., Ramsey-Goldman, R., Nived, O., Jönsen, A., Steinsson, K., Zoma, A.A., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Ỉnanç, M., van Vollenhoven, R., Ramos-Casals, M., Kamen, D.L., Jacobsen, S., Peschken, C.A., Askanase, A., Stoll, T., Arthritis and Rheumatology, 2020, 10.1002/art.41392
  • Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry, Zuily, S., Clerc-Urmès, I., Bauman, C., Andrade, D., Sciascia, S., Pengo, V., Tektonidou, M.G., Ugarte, A., Gerosa, M., Michael Belmont, H., Zamorano, M.A.A., Fortin, P., Ji, L., Efthymiou, M., Cohen, H., Branch, D.W., Jesus, G.R.D., Nalli, C., Petri, M., Rodriguez, E., Cervera, R., Knight, J.S., Atsumi, T., Willis, R., Bertolaccini, M.L., Vega, J., Wahl, D., Erkan, D., Lupus, 2020, 10.1177/0961203320940776
  • Construction of a frailty index as a novel health measure in systemic lupus erythematosus, Legge, A., Kirkland, S., Rockwood, K., Andreou, P., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Wallace, D.J., Bernatsky, S., Clarke, A.E., Merrill, J.T., Ginzler, E.M., Fortin, P., Gladman, D.D., Urowitz, M.B., Bruce, I.N., Isenberg, D.A., Rahman, A., Alarcon, G.S., Petri, M., Khamashta, M.A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Zoma, A.A., Aranow, C., MacKay, M., Ruiz-Irastorza, G., Lim, S.S., Inanc, M., Van Vollenhoven, R.F., Jonsen, A., Nived, O., Ramos-Casals, M., Kamen, D.L., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Askanase, A., Hanly, J.G., Journal of Rheumatology, 2020, 10.3899/jrheum.181338
  • Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map, Toupin-April, K., Huber, A.M., Duffy, C.M., Proulx, L., Morgan, E.M., Cohen, J.S., Gaboury, I., Li, L.C., Tugwell, P., Stinson, J., Couchman, D., Berbatovci, F., Boyd, A., Sachs, H., Sirois, A., Sivakumar, A., Ragusa, M., El Hindi, T., Stringer, E., Cavallo, S., Ueffing, E., Gibbon, M., Fortin, P.R., Brinkman, W., Connelly, M., Weiss, J.E., Gmuca, S., Décary, S., Patient, 2020, 10.1007/s40271-020-00458-z
  • Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach, Barber, M.R.W., Hanly, J.G., Su, L., Urowitz, M.B., St. Pierre, Y., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Dooley, M.A., Fortin, P.R., Gladman, D.D., Sanchez-Guerrero, J., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Mackay, M., Alarcón, G.S., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Farewell, V., Stoll, T., Buyon, J., Clarke, A.E., Arthritis Care and Research, 2020, 10.1002/acr.24092
  • FcgRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus, Melki, I., Allaeys, I., Tessandier, N., Mailhot, B., Cloutier, N., Campbell, R.A., Rowley, J.W., Salem, D., Zufferey, A., Laroche, A., Lévesque, T., Patey, N., Rauch, J., Lood, C., Droit, A., McKenzie, S.E., Machlus, K.R., Rondina, M.T., Lacroix, S., Fortin, P.R., Boilard, E., Blood, 2020, 10.1182/blood.2020004974
  • IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species, Huot, S., Laflamme, C., Fortin, P.R., Boilard, E., Pouliot, M., FASEB Journal, 2020, 10.1096/fj.202001085R
  • Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS), Zheng, B., Hudson, M., Wang, M., Baron, M., Pope, J.E., Baron, M., Hudson, M., Gyger, G., Larché, M.J., Khalidi, N.A., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Maltez, N., Smith, D., Thorne, C., Ikic, A., Fortin, P.R., Fritzler, M.J., Arthritis Research and Therapy, 2020, 10.1186/s13075-020-02220-0
  • Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Hanly, J.G., Li, Q., Su, L., Urowitz, M.B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A.E., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Fortin, P.R., Gladman, D.D., Bruce, I.N., Petri, M., Ginzler, E.M., Dooley, M.A., Steinsson, K., Ramsey-Goldman, R., Zoma, A.A., Manzi, S., Nived, O., Jonsen, A., Khamashta, M.A., Alarcón, G.S., Svenungsson, E., van Vollenhoven, R.F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Ramos-Casals, M., Lim, S.S., Inanc, M., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Askanase, A., Theriault, C., Farewell, V., Arthritis and Rheumatology, 2020, 10.1002/art.41070
  • Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome, Becker, Y.L.C., Julien, A.-S., Godbout, A., Boilard, É., Fortin, P.R., Lupus, 2020, 10.1177/0961203320944481
  • Platelets disseminate extracellular vesicles in lymph in rheumatoid arthritis, Tessandier, N., Melki, I., Cloutier, N., Allaeys, I., Miszta, A., Tan, S., Milasan, A., Michel, S., Benmoussa, A., Lévesque, T., Côté, F., McKenzie, S.E., Gilbert, C., Provost, P., Brisson, A.R., Wolberg, A.S., Fortin, P.R., Martel, C., Boilard, É., Arteriosclerosis, Thrombosis, and Vascular Biology, 2020, 10.1161/ATVBAHA.119.313698
  • Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index, Legge, A., Kirkland, S., Rockwood, K., Andreou, P., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Wallace, D.J., Bernatsky, S., Clarke, A.E., Merrill, J.T., Ginzler, E.M., Fortin, P.R., Gladman, D.D., Urowitz, M.B., Bruce, I.N., Isenberg, D.A., Rahman, A., Alarcón, G.S., Petri, M., Khamashta, M.A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Zoma, A.A., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S.S., Inanc, M., van Vollenhoven, R.F., Jonsen, A., Nived, O., Ramos-Casals, M., Kamen, D.L., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Askanase, A., Hanly, J.G., Arthritis and Rheumatology, 2020, 10.1002/art.41144
  • Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis, Ortel, T.L., Meleth, S., Catellier, D., Crowther, M., Erkan, D., Fortin, P.R., Garcia, D., Haywood, N., Kosinski, A.S., Levine, S.R., Phillips, M.J., Whitehead, N., Journal of Thrombosis and Haemostasis, 2020, 10.1111/jth.14936
  • Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus, Enocsson, H., Wirestam, L., Dahle, C., Padyukov, L., Jönsen, A., Urowitz, M.B., Gladman, D.D., Romero-Diaz, J., Bae, S.-C., Fortin, P.R., Sanchez-Guerrero, J., Clarke, A.E., Bernatsky, S., Gordon, C., Hanly, J.G., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Ginzler, E., Alarcón, G.S., Chatham, W.W., Petri, M., Khamashta, M., Aranow, C., Mackay, M., Dooley, M.A., Manzi, S., Ramsey-Goldman, R., Nived, O., Steinsson, K., Zoma, A.A., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., van Vollenhoven, R.F., Ramos-Casals, M., Kamen, D.L., Jacobsen, S., Peschken, C.A., Askanase, A., Stoll, T., Bruce, I.N., Wetterö, J., Sjöwall, C., Journal of Autoimmunity, 2020, 10.1016/j.jaut.2019.102340
  • A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort, Kim, H., Levy, D.M., Silverman, E.D., Hitchon, C., Bernatsky, S., Pineau, C., Smith, C.D., Tucker, L., Petty, R., Arbillaga, H., Zummer, M., Hudson, M., Fortin, P., Huber, A.M., Chedeville, G., Peschken, C., Pope, J.E., Rheumatology (United Kingdom), 2019, 10.1093/rheumatology/kez006
  • Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations, Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., Eder, L., Wagner, É., Pelletier, M., Hajj, H.E., Tremblay, M.-È., Belleannée, C., Hébert, M.-J., Dieudé, M., Rauch, J., Fortin, P.R., Boilard, E., Scientific Reports, 2019, 10.1038/s41598-019-40900-3
  • Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort, Choi, M.Y., Clarke, A.E., St. Pierre, Y., Hanly, J.G., Urowitz, M.B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Dooley, M.A., Fortin, P.R., Gladman, D.D., Sanchez-Guerrero, J., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Alarcón, G.S., Manzi, S., Nived, O., Zoma, A.A., van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Stoll, T., Buyon, J., Mahler, M., Fritzler, M.J., Arthritis Care and Research, 2019, 10.1002/acr.23712
  • Autoantibodies in systemic lupus erythematosus target mitochondrial RNA, Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P.R., Boilard, E., Frontiers in Immunology, 2019, 10.3389/fimmu.2019.01026
  • Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository, Efthymiou, M., Mackie, I.J., Lane, P.J., Andrade, D., Willis, R., Erkan, D., Sciascia, S., Krillis, S., Bison, E., Borges Galhardo Vendramini, M., Romay-Penabad, Z., Qi, M., Tektonidou, M., Ugarte, A., Chighizola, C., Belmont, H.M., Aguirre, M.A., Ji, L., Branch, D.W., de Jesus, G., Fortin, P.R., Andreoli, L., Petri, M., Cervera, R., Rodriguez, E., Knight, J.S., Atsumi, T., Vega, J., Sevim, E., Bertolaccini, M.L., Pengo, V., Cohen, H., Journal of Thrombosis and Haemostasis, 2019, 10.1111/jth.14596
  • Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice, Cesaro, A., Defrêne, J., Lachhab, A., Pagé, N., Tardif, M.R., Al-Shami, A., Oravecz, T., Fortin, P.R., Daudelin, J.-F., Labrecque, N., Aoudjit, F., Pelletier, M., Tessier, P.A., PLoS ONE, 2019, 10.1371/journal.pone.0221528
  • Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus, Legge, A., Kirkland, S., Rockwood, K., Andreou, P., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Wallace, D.J., Bernatsky, S., Clarke, A.E., Merrill, J., Ginzler, E.M., Fortin, P., Gladman, D.D., Urowitz, M.B., Bruce, I.N., Isenberg, D., Rahman, A., Alarcón, G.S., Petri, M., Khamashta, M.A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Steinsson, K., Zoma, A.A., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S.S., Inanc, M., van Vollenhoven, R.F., Jonsen, A., Nived, O., Ramos-Casals, M., Kamen, D.L., Kalunian, K., Jacobsen, S., Peschken, C.A., Askanase, A., Hanly, J.G., Arthritis and Rheumatology, 2019, 10.1002/art.40859
  • Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study, de Jesús, G.R., Sciascia, S., Andrade, D., Barbhaiya, M., Tektonidou, M., Banzato, A., Pengo, V., Ji, L., Meroni, P.L., Ugarte, A., Cohen, H., Branch, D.W., Andreoli, L., Belmont, H.M., Fortin, P.R., Petri, M., Rodriguez, E., Cervera, R., Knight, J.S., Atsumi, T., Willis, R., Nascimento, I.S., Rosa, R., Erkan, D., Levy, R.A., BJOG: An International Journal of Obstetrics and Gynaecology, 2019, 10.1111/1471-0528.15469
  • Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort, Mendel, A., Bernatsky, S.B., Hanly, J.G., Urowitz, M.B., Clarke, A.E., Romero-Diaz, J., Gordon, C., Bae, S.-C., Wallace, D.J., Merrill, J.T., Buyon, J.P., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Dooley, M.A., Fortin, P.R., Gladman, D.D., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Mackay, M., Alarcón, G.S., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, Sø., Askanase, A., Sanchez-Guerrero, J., Bruce, I.N., Costedoat-Chalumeau, N., Vinet, E., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2018-214434
  • Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis, Salituri, J., Patey, N., Takano, T., Fiset, P., Del Rincon, S., Berkson, L., Baron, M., Hudson, M., Baron, M., Hudson, M., Gyger, G., Pope, J., Larché, M., Khalidi, N., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Smith, D., Thorne, C., Fortin, P.R., Fritzler, M., Journal of Scleroderma and Related Disorders, 2019, 10.1177/2397198319885488
  • Neuropsychiatric events in systemic lupus erythematosus: A longitudinal analysis of outcomes in an international inception cohort using a multistate model approach, Hanly, J.G., Urowitz, M.B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A.E., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Fortin, P.R., Gladman, D.D., Bruce, I.N., Petri, M., Ginzler, E.M., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Jönsen, A., Alarcón, G.S., Van Vollenhoven, R.F., Aranow, C., MacKay, M., Ruiz-Irastorza, G., Lim, S., Inanc, M., Kalunian, K.C., Jacobsen, Sø., Peschken, C.A., Kamen, D.L., Askanase, A., Farewell, V., Annals of the Rheumatic Diseases, 2019, 10.1136/annrheumdis-2019-216150
  • Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort, Wirestam, L., Enocsson, H., Skogh, T., Padyukov, L., Jönsen, A., Urowitz, M.B., Gladman, D.D., Romero-DIaz, J., Bae, S.-C., Fortin, P.R., Sanchez-Guerrero, J., Clarke, A.E., Bernatsky, S., Gordon, C., Hanly, J.G., Wallace, D., Isenberg, D.A., Rahman, A., Merrill, J., Ginzler, E., Alarcón, G.S., Chatham, W.W., Petri, M., Khamashta, M., Aranow, C., MacKay, M., Dooley, M.A., Manzi, S., Ramsey-Goldman, R., Nived, O., Steinsson, K., Zoma, A., Ruiz-Irastorza, G., Lim, S., Kalunian, K., Inanc, M., Van Vollenhoven, R., Ramos-Casals, M., Kamen, D.L., Jacobsen, S., Peschken, C., Askanase, A., Stoll, T., Bruce, I.N., Wetterö, J., Sjöwall, C., Journal of Rheumatology, 2019, 10.3899/jrheum.180713
  • Persistent disease activity remains a burden for patients with systemic lupus erythematosus, Peschken, C.A., Wang, Y., Abrahamowicz, M., Pope, J., Silverman, E., Sayani, A., Iczkovitz, S., Ross, J., Zummer, M., Tucker, L., Pineau, C., Levy, D., Hudson, M., Hitchon, C.A., Huber, A.M., Smith, C.D., Avina-Zubieta, A., Arbillaga, H., Chédeville, G., Wynant, W., Fortin, P.R., Journal of Rheumatology, 2019, 10.3899/jrheum.171454
  • Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Hanly, J.G., Li, Q., Su, L., Urowitz, M.B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A.E., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Fortin, P.R., Gladman, D.D., Bruce, I.N., Petri, M., Ginzler, E., Dooley, M.A., Steinsson, K., Ramsey-Goldman, R., Zoma, A.A., Manzi, S., Nived, O., Jonsen, A., Khamashta, M.A., Alarcón, G.S., van Vollenhoven, R.F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Ramos-Casals, M., Lim, S.S., Inanc, M., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Askanase, A., Theriault, C., Farewell, V., Arthritis and Rheumatology, 2019, 10.1002/art.40764
  • Response to Middleton KR et als. Yoga and SLE, Lee, J., Pineau, C.A., Da Costa, D., Clarke, A.E., Fortin, P.R., Neville, C., Neville, A., Bernatsky, S., Complementary Therapies in Medicine, 2019, 10.1016/j.ctim.2019.02.019
  • The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort, Radin, M., Sciascia, S., Erkan, D., Pengo, V., Tektonidou, M.G., Ugarte, A., Meroni, P., Ji, L., Belmont, H.M., Cohen, H., Ramires de Jesús, G., Branch, D.W., Fortin, P.R., Andreoli, L., Petri, M., Rodriguez, E., Rodriguez-Pinto, I., Knight, J.S., Atsumi, T., Willis, R., Gonzalez, E., Lopez-Pedrera, R., Rossi Gandara, A.P., Borges Gualhardo Vendramini, M., Banzato, A., Sevim, E., Barbhaiya, M., Efthymiou, M., Mackie, I., Bertolaccini, M.L., Andrade, D., Seminars in Arthritis and Rheumatism, 2019, 10.1016/j.semarthrit.2019.04.009
  • The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis, Sciascia, S., Willis, R., Pengo, V., Krilis, S., Andrade, D., Tektonidou, M.G., Ugarte, A., Chighizola, C., Branch, D.W., Levy, R.A., Nalli, C., Fortin, P.R., Petri, M., Rodriguez, E., Rodriguez-Pinto, I., Atsumi, T., Nascimento, I., Rosa, R., Banzato, A., Erkan, D., Cohen, H., Efthymiou, M., Mackie, I., Bertolaccini, M.L., Thrombosis Research, 2019, 10.1016/j.thromres.2019.01.010
  • The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository, Unlu, O., Erkan, D., Barbhaiya, M., Andrade, D., Nascimento, I., Rosa, R., Banzato, A., Pengo, V., Ugarte, A., Gerosa, M., Ji, L., Efthymiou, M., Branch, D.W., de Jesus, G.R., Tincani, A., Belmont, H.M., Fortin, P.R., Petri, M., Rodriguez, E., Pons-Estel, G.J., Knight, J.S., Atsumi, T., Willis, R., Zuily, S., Tektonidou, M.G., Arthritis Care and Research, 2019, 10.1002/acr.23584
  • Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen, Mendel, A., Bernatsky, S., Pineau, C.A., St-Pierre, Y., Hanly, J.G., Urowitz, M.B., Clarke, A.E., Romero-Diaz, J., Gordon, C., Bae, S.-C., Wallace, D.J., Merrill, J.T., Buyon, J., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Dooley, M.A., Fortin, P., Gladman, D.D., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., MacKay, M., Alarcón, G., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, Sø., Askanase, A., Sanchez-Guerrero, J., Bruce, I.N., Costedoat-Chalumeau, N., Vinet, E., Rheumatology (United Kingdom), 2019, 10.1093/rheumatology/kez014
  • Alpha2beta1 integrin (VLA-2) protects activated human effector T cells from methotrexate-induced apoptosis, Abderrazak, A., El Azreq, M.-A., Naci, D., Fortin, P.R., Aoudjit, F., Frontiers in Immunology, 2018, 10.3389/fimmu.2018.02269
  • Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype, Fritzler, M.J., Hudson, M., Choi, M.Y., Mahler, M., Wang, M., Bentow, C., Milo, J., Baron, M., Pope, J., Baron, M., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Hudson, M., Ligier, S., Grodzicky, T., LeClercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Abu-Hakima, M., Rodriguez-Reyna, T.S., Cabral, A.R., Fritzler, M.J., Autoimmunity Reviews, 2018, 10.1016/j.autrev.2018.01.006
  • Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment, Chan, K., Clarke, A.E., Ramsey-Goldman, R., Foulkes, W., Tessier Cloutier, B., Urowitz, M.B., Gladman, D., Nived, O., Romero-Diaz, J., Petri, M., Ginzler, E., Fortin, P.R., Bae, S.C., Wallace, D.J., Yelin, E.H., Bernatsky, S., Lupus, 2018, 10.1177/0961203317713146
  • Canadian rheumatology association recommendations for the assessment and monitoring of systemic lupus erythematosus, Keeling, S.O., Alabdurubalnabi, Z., Avina-Zubieta, A., Barr, S., Bergeron, L., Bernatsky, S., Bourre-Tessier, J., Clarke, A., Baril-Dionne, A., Dutz, J., Ensworth, S., Fifi-Mah, A., Fortin, P.R., Gladman, D.D., Haaland, D., Hanly, J.G., Hiraki, L.T., Hussein, S., Legault, K., Levy, D., Lim, L., Matsos, M., McDonald, E.G., Medina-Rosas, J., Pardi, J.P., Peschken, C., Pineau, C., Pope, J., Rader, T., Reynolds, J., Silverman, E., Tselios, K., Suitner, M., Urowitz, M., Touma, Z., Vinet, E., Santesso, N., Journal of Rheumatology, 2018, 10.3899/jrheum.171459
  • Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study, Hanly, J.G., Li, Q., Su, L., Urowitz, M.B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A.E., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Fortin, P., Gladman, D.D., Bruce, I.N., Petri, M., Ginzler, E.M., Dooley, M.A., Steinsson, K., Ramsey-Goldman, R., Zoma, A.A., Manzi, S., Nived, O., Jonsen, A., Khamashta, M.A., Alarcón, G.S., Chatham, W., van Vollenhoven, R.F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Ramos-Casals, M., Lim, S.S., Inanc, M., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Askanase, A., Theriault, C., Farewell, V., Arthritis Care and Research, 2018, 10.1002/acr.23509
  • Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach, Barber, M.R.W., Hanly, J.G., Su, L., Urowitz, M.B., St. Pierre, Y., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Wallace, D.J., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Fortin, P.R., Gladman, D.D., Sanchez-Guerrero, J., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Mackay, M., Alarcón, G.S., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Theriault, C., Farewell, V., Clarke, A.E., Arthritis Care and Research, 2018, 10.1002/acr.23480
  • Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort, Little, J., Parker, B., Lunt, M., Hanly, J.G., Urowitz, M.B., Clarke, A.E., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Wallace, D.J., Merrill, J.T., Buyon, J., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Dooley, M.A., Fortin, P., Gladman, D.D., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Mackay, M., Alarcón, G.S., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Sanchez-Guerrero, J., Bruce, I.N., Rheumatology (United Kingdom), 2018, 10.1093/rheumatology/kex444
  • Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms, Wither, J.E., Prokopec, S.D., Noamani, B., Chang, N.-H., Bonilla, D., Touma, Z., Avila-Casado, C., Reich, H.N., Scholey, J., Fortin, P.R., Boutros, P.C., Landolt-Marticorena, C., PLoS ONE, 2018, 10.1371/journal.pone.0196117
  • Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group, Sakr, L., Hudson, M., Wang, M., Younanian, E., Baron, M., Bernatsky, S., Pope, J., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Hudson, M., Ligier, S., Grodzicky, T., Leclercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Abu-Hakima, M., Rodriguez-Reyna, T.S., Cabral, A.R., Fritzler, M., Journal of Scleroderma and Related Disorders, 2018, 10.1177/2397198318766825
  • Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration, Cloutier, N., Allaeys, I., Marcoux, G., Machlus, K.R., Mailhot, B., Zufferey, A., Levesque, T., Becker, Y., Tessandier, N., Melki, I., Zhi, H., Poirier, G., Rondina, M.T., Italiano, J.E., Flamand, L., McKenzie, S.E., Cote, F., Nieswandt, B., Khan, W.I., Flick, M.J., Newman, P.J., Lacroix, S., Fortin, P.R., Boilard, E., Proceedings of the National Academy of Sciences of the United States of America, 2018, 10.1073/pnas.1720553115
  • Practice variations in the diagnosis, monitoring, and treatment of systemic lupus erythematosus in Canada, Keeling, S.O., Bissonauth, A., Bernatsky, S., Vandermeer, B., Fortin, P.R., Gladman, D.D., Peschken, C., Urowitz, M.B., Journal of Rheumatology, 2018, 10.3899/jrheum.171307
  • Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol, Carrier, M.-E., Kwakkenbos, L., Boutron, I., Welling, J., Sauve, M., van den Ende, C., Schouffoer, A.A., Hudson, M., Thombs, B.D., Mouthon, L., Baron, M., Bartlett, S.J., Furst, D., Gottesman, K., van den Hoogen, F., Malcarne, V., Mayes, M.D., Nielson, W.R., Riggs, R., Wigley, F., Assassi, S., Maia, A.C., El-Baalbaki, G., Ells, C., Fligelstone, K., Fortune, C., Frech, T., Godard, D., Harel, D., Impens, A., Jang, Y., Johnson, S.R., Kennedy, A.T., Körner, A., Larche, M., Leite, C., Marra, C., Nielsen, K., Pope, J., Portales, A., Reyna, T.S.R., Steele, R.J., Suarez-Almazor, M.E., Wong-Rieger, D., Agard, C., Albert, A., André, M., Arsenault, G., Benmostefa, N., Benzida, I., Berthier, S., Bissonnette, L., Boire, G., Bruns, A., Carreira, P., Casadevall, M., Chaigne, B., Chung, L., Cohen, P., Dagenais, P., Denton, C., Domsic, R., Dunne, J.V., Fare, R., Farge-Bancel, D., Fortin, P.R., Gill, A., Gordon, J., Granel-Rey, B., Grange, C., Gyger, G., Hachulla, E., Hatron, P.-Y., Herrick, A.L., Hij, A., Hinchcliff, M., Ikic, A., Jones, N., Fernandes, A.J.B., Kafaja, S., Khalidi, N., Korman, B., Lambert, M., Launay, D., Liang, P., London, J., Luna, D., Manning, J., Martin, M., Martin, T., Masetto, A., Maurier, F., Mekinian, A., Paule, R., Régent, A., Rivière, S., Robinson, D., Rodriguez, E., Roux, S., Smets, P., Smith, D., Sobanski, V., Spiera, R., Steen, V., Sutton, E., Terrier, B., Thorne, C., Varga, J., Wilcox, P., Cumin, J., Fox, R.S., Gholizadeh, S., Jewett, L.R., Levis, B., Mills, S.D., Pepin, M.R., Turner, K., Journal of Scleroderma and Related Disorders, 2018, 10.5301/jsrd.5000263
  • Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study, Fox, R.S., Kwakkenbos, L., Carrier, M.-E., Mills, S.D., Gholizadeh, S., Jewett, L.R., Roesch, S.C., Merz, E.L., Assassi, S., Furst, D.E., Gottesman, K., Mayes, M.D., Thombs, B.D., Malcarne, V.L., Baron, M., Bartlett, S.J., Ells, C., Hudson, M., Jang, Y., Körner, A., Kafaja, S., van den Hoogen, F., Assassi, S., Mouthon, L., Nielson, W.R., Riggs, R., Nielsen, K., Wigley, F., Boutron, I., Maia, A.C., Leite, C., El-Baalbaki, G., van den Ende, C., Fligelstone, K., Frech, T., Godard, D., Harel, D., Impens, A., Johnson, S.R., Kennedy, A.T., Khalidi, N., Marra, C., Pope, J., Portales, A., Luna, D., Schouffoer, A.A., Levis, B., Suarez-Almazor, M.E., Welling, J., Wong-Rieger, D., Agard, C., Ikic, A., Smets, P., Roux, S., Terrier, B., Hij, A., Berthier, S., Rodriguez, E., Chung, L., Gill, A., Domsic, R., Wilcox, P., Fortin, P.R., Spiera, R., Granel-Rey, B., Grange, C., Sobanski, V., Herrick, A.L., Varga, J., Jones, N., Manning, J., Martin, T., Maurier, F., Rivière, S., Robinson, D., Smith, D., Steen, V., Sutton, E., Thorne, C., Turner, K., Arthritis Care and Research, 2018, 10.1002/acr.23532
  • Sharing ongoing care with primary care physicians opens up opportunity for timelier and earlier care by rheumatologists for patients with new inflammatory polyarthritis, Nguyen, P., Julien, A.-S., Bessette, L., Fortin, P.R., Michou, L., Journal of Rheumatology, 2018, 10.3899/jrheum.170494
  • Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus, Bernatsky, S., Ramsey-Goldman, R., Petri, M., Urowitz, M.B., Gladman, D.D., Fortin, P.R., Yelin, E.H., Ginzler, E., Hanly, J.G., Peschken, C., Gordon, C., Nived, O., Aranow, C., Bae, S.-C., Isenberg, D., Rahman, A., Hansen, J.E., Pierre, Y.S., Clarke, A.E., Journal of Rheumatology, 2018, 10.3899/jrheum.170652
  • Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients, Isenberg, D., Sturgess, J., Allen, E., Aranow, C., Askanase, A., Sang-Cheol, B., Bernatsky, S., Bruce, I., Buyon, J., Cervera, R., Clarke, A., Dooley, M.A., Fortin, P., Ginzler, E., Gladman, D., Hanly, J., Inanc, M., Jacobsen, S., Kamen, D., Khamashta, M., Lim, S., Manzi, S., Nived, O., Peschken, C., Petri, M., Kalunian, K., Rahman, A., Ramsey-Goldman, R., Romero-Diaz, J., Ruiz-Irastorza, G., Sanchez-Guerrero, J., Steinsson, K., Sturfelt, G., Urowitz, M., van Vollenhoven, R., Wallace, D.J., Zoma, A., Merrill, J., Gordon, C., Arthritis Care and Research, 2018, 10.1002/acr.23252
  • The non-haemostatic role of platelets in systemic lupus erythematosus, Linge, P., Fortin, P.R., Lood, C., Bengtsson, A.A., Boilard, E., Nature Reviews Rheumatology, 2018, 10.1038/nrrheum.2018.38
  • The scleroderma patient-centered intervention network cohort: Baseline clinical features and comparison with other large scleroderma cohorts, Dougherty, D.H., Kwakkenbos, L., Carrier, M.-E., Salazar, G., Assassi, S., Baron, M., Bartlett, S.J., Furst, D.E., Gottesman, K., Van Den Hoogen, F., Malcarne, V.L., Mouthon, L., Nielson, W.R., Poiraudeau, S., Sauvé, M., Boire, G., Bruns, A., Chung, L., Denton, C., Dunne, J.V., Fortin, P., Frech, T., Gill, A., Gordon, J., Herrick, A.L., Hinchcliff, M., Hudson, M., Johnson, S.R., Jones, N., Kafaja, S., Larché, M., Manning, J., Pope, J., Spiera, R., Steen, V., Sutton, E., Thorne, C., Wilcox, P., Thombs, B.D., Mayes, M.D., Albert, A., Arsenault, G., Bissonette, L., Boutron, I., Carreira, P., Maia, A.C., Dagenais, P., Domsic, R., El-Baalbaki, G., Ells, C., Van Den Ende, C., Fligelstone, K., Fortune, C., Godard, D., Gyger, G., Harel, D., Ikic, A., Impens, A., Jang, Y., Fernandes, A.J.D.B., Kennedy, A.T., Khalidi, N., Korman, B., Leite, C., Liang, P., Marra, C., Masetto, A., Nielsen, K., Portales, A., Riggs, R., Robinson, D., Reyna, T.S.R., Roux, S., Schouffoer, A.A., Smith, D., Steele, R.J., Suarez-Almazor, M.E., Varga, J., Welling, J., Wigley, F., Wong-Rieger, D., Cumin, J., Delisle, V.C., Fedoruk, C., Fox, R.S., Gholizadeh, S., Jewett, L.R., Levis, B., Mills, S.D., Pepin, M.R., Persmann, J., Turner, K., Rheumatology (United Kingdom), 2018, 10.1093/rheumatology/key139
  • Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study, Mills, S.D., Kwakkenbos, L., Carrier, M.-E., Gholizadeh, S., Fox, R.S., Jewett, L.R., Gottesman, K., Roesch, S.C., Thombs, B.D., Malcarne, V.L., Baron, M., Bartlett, S.J., Ells, C., Hudson, M., Jang, Y., Körner, A., Furst, D., Kafaja, S., van den Hoogen, F., Mayes, M.D., Assassi, S., Mouthon, L., Nielson, W.R., Riggs, R., Sauve, M., Fortune, C., Nielsen, K., Wigley, F., Boutron, I., Maia, A.C., Leite, C., El-Baalbaki, G., van den Ende, C., Fligelstone, K., Frech, T., Godard, D., Harel, D., Impens, A., Johnson, S.R., Kennedy, A.T., Larche, M., Khalidi, N., Marra, C., Pope, J., Portales, A., Rodriguez Reyna, T.S., Luna, D., Schouffoer, A.A., Steele, R.J., Gyger, G., Levis, B., Suarez-Almazor, M.E., Welling, J., Wong-Rieger, D., Agard, C., Albert, A., Ikic, A., André, M., Smets, P., Arsenault, G., Bissonnette, L., Boire, G., Bruns, A., Dagenais, P., Fernandes, A.J.D.B., Liang, P., Masetto, A., Roux, S., Benmostefa, N., Casadevall, M., Chaigne, B., Cohen, P., London, J., Paule, R., Régent, A., Terrier, B., Benzidia, I., Farge-Bancel, D., Hij, A., Berthier, S., Carreira, P., Fare, R., Martin, M., Melchor, S., Rodriguez, E., Chung, L., Denton, C., Gill, A., Domsic, R., Dunne, J.V., Wilcox, P., Fortin, P.R., Gordon, J., Spiera, R., Granel-Rey, B., Grange, C., Hachulla, E., Hatron, P.-Y., Lambert, M., Launay, D., Sobanski, V., Herrick, A.L., Hinchcliff, M., Korman, B., Varga, J., Jones, N., Manning, J., Martin, T., Maurier, F., Mekinian, A., Rivière, S., Robinson, D., Smith, D., Steen, V., Sutton, E., Thorne, C., Cumin, J., Pepin, M.R., Turner, K., Arthritis Care and Research, 2018, 10.1002/acr.23514
  • Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study, Gholizadeh, S., Kwakkenbos, L., Carrier, M.-E., Mills, S.D., Fox, R.S., Jewett, L.R., Gottesman, K., Roesch, S., Thombs, B.D., Malcarne, V.L., Baron, M., Bartlett, S.J., Furst, D., Van Den Hoogen, F., Mayes, M.D., Mouthon, L., Nielson, W.R., Poiraudeau, S., Riggs, R., Sauve, M., Wigley, F., Assassi, S., Boutron, I., Maia, A.C., El-Baalbaki, G., Ells, C., Van Den Ende, C., Fligelstone, K., Fortune, C., Frech, T., Godard, D., Harel, D., Hudson, M., Impens, A., Jang, Y., Johnson, S.R., Kennedy, A.T., Larche, M., Leite, C., Marra, C., Nielsen, K., Pope, J., Portales, A., Reyna, T.S.R., Schouffoer, A.A., Steele, R.J., Suarez-Almazor, M.E., Welling, J., Wong-Rieger, D., Albert, A., Arsenault, G., Bissonnette, L., Boire, G., Bruns, A., Carreira, P., Chung, L., Dagenais, P., Denton, C., Domsic, R., Dunne, J.V., Fortin, P., Gill, A., Gordon, J., Gyger, G., Herrick, A.L., Hinchcliff, M., Ikic, A., Jones, N., Fernandes, A.J.D.B., Kafaja, S., Khalidi, N., Korman, B., Liang, P., Manning, J., Masetto, A., Robinson, D., Roux, S., Smith, D., Spiera, R., Steen, V., Sutton, E., Thorne, C., Varga, J., Wilcox, P., Delisle, V.C., Fedoruk, C., Levis, B., Pepin, M.R., Persmann, J., Journal of Scleroderma and Related Disorders, 2018, 10.5301/jsrd.5000264
  • A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs), Greenfield, J., Hudson, M., Vinet, E., Fortin, P.R., Bykerk, V., Pineau, C.A., Wang, M., Bernatsky, S., Baron, M., PLoS ONE, 2017, 10.1371/journal.pone.0189840
  • Breast cancer in systemic lupus, Bernatsky, S., Ramsey-Goldman, R., Petri, M., Urowitz, M.B., Gladman, D.D., Fortin, P.F., Ginzler, E., Romero-Diaz, J., Peschken, C., Jacobsen, S., Hanly, J.G., Gordon, C., Nived, O., Yelin, E.H., Isenberg, D., Rahman, A., Bae, S.-C., Joseph, L., Witte, T., Ruiz-Irastorza, G., Aranow, C., Kamen, D., Sturfeldt, G., Foulkes, W.D., Hansen, J.E., St Pierre, Y., Raymer, P.C., Tessier-Cloutier, B., Clarke, A.E., Lupus, 2017, 10.1177/0961203316664595
  • Clinical correlates of faecal incontinence in systemic sclerosis: Identifying therapeutic avenues, Richard, N., Hudson, M., Gyger, G., Baron, M., Sutton, E., Khalidi, N., Pope, J.E., Carrier, N., Larché, M., Albert, A., Fortin, P.R., Thorne, C., Masetto, A., Pope, J., Mathieu, J.-P., Ligier, S., Grodzicky, T., Gyger, G., Markland, J., Robinson, D., Jones, N., Docherty, P., Kaminska, E., LeClercq, S., Masetto, A., Sutton, E., Thorne, C., Smith, D., Fortin, P.R., Abu-Hakima, M., Rodriguez-Reyna, T.S., Cabral, A.R., Fritzler, M., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kew441
  • Early Mortality in a Multinational Systemic Sclerosis Inception Cohort, Hao, Y., Hudson, M., Baron, M., Carreira, P., Stevens, W., Rabusa, C., Tatibouet, S., Carmona, L., Joven, B.E., Huq, M., Proudman, S., Nikpour, M., Abu-Hakima, M., Cabral, A.R., Docherty, P., Fortin, P.R., Fritzler, M., Grodzicky, T., Gyger, G., Hudson, M., Jones, N., Kaminska, E., Khalidi, N., Larché, M., LeClercq, S., Ligier, S., Markland, J., Masetto, A., Mathieu, J.-P., Pope, J., Robinson, D., Rodriguez-Reyna, T.S., Smith, D., Sutton, E., Thorne, C., Proudman, S., Roddy, J., Sahhar, J., Stevens, W., Walker, J., Youssef, P., Zochling, J., Arthritis and Rheumatology, 2017, 10.1002/art.40027
  • Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus, George, A., Wong-Pak, A., Peschken, C.A., Silverman, E., Pineau, C., Smith, C.D., Arbillaga, H., Zummer, M., Bernatsky, S., Hudson, M., Hitchon, C., Fortin, P.R., Nevskaya, T., Pope, J.E., Arthritis Care and Research, 2017, 10.1002/acr.22922
  • Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study, Ferreira, I., Croca, S., Raimondo, M.G., Matharu, M., Miller, S., Giles, I., Isenberg, D., Ioannou, Y., Hanly, J.G., Urowitz, M.B., Anderson, N., Aranow, C., Askanase, A., Bae, S.-C., Bernatsky, S., Bruce, I.N., Buyon, J., Clarke, A.E., Dooley, M.A., Fortin, P., Ginzler, E., Gladman, D., Gordon, C., Inanc, M., Jacobsen, S., Kalunian, K., Kamen, D., Khamashta, M., Lim, S., Manzi, S., Merrill, J., Nived, O., Peschken, C., Petri, M., Ramsey-Goldman, R., Ruiz-Irastorza, G., Sanchez-Guerrero, J., Steinson, K., Sturfelt, G.K., van Vollenhoven, R., Wallace, D.J., Zoma, A., Rahman, A., Arthritis Research and Therapy, 2017, 10.1186/s13075-017-1495-6
  • Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort, Nevskaya, T., Baron, M., Pope, J.E., Hudson, M., Gyger, G., Larché, M.J., Khalidi, N.A., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Smith, D., Thorne, C., Fortin, P.R., Fritzler, M.J., Rheumatology (United Kingdom), 2017, 10.1093/rheumatology/kex015
  • Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis, Li, G., Adachi, J.D., Cheng, J., Thabane, L., Hudson, M., Fritzler, M.J., Lorenzi, S., Baron, M., Larché, M., Hudson, M., Gyger, G., Larché, M., Pope, J., Khalidi, N., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Smith, D., Thorne, C., Fortin, P.R., Fritzler, M., Clinical and Experimental Rheumatology, 2017
  • Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study, Jean, S., Hudson, M., Gamache, P., Bessette, L., Fortin, P.R., Boire, G., Bernatsky, S., Clinical Rheumatology, 2017, 10.1007/s10067-017-3796-1
  • The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients, Levis, B., Kwakkenbos, L., Hudson, M., Baron, M., Thombs, B.D., and the Canadian Scleroderma Research Group, Hudson, M., Gyger, G., Pope, J., Larché, M., Khalidi, N., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Smith, D., Thorne, C., Fortin, P.R., Fritzler, M., Clinical Rheumatology, 2017, 10.1007/s10067-016-3501-9
  • The comparability of functional assessment of chronic illness therapy - Fatigue scores between cancer and systemic sclerosis, Coroiu, A., Kwakkenbos, L., Levis, B., Hudson, M., Baron, M., Cella, D., Thombs, B.D., Gyger, G., Pope, J., Larché, M., Khalidi, N., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Smith, D., Thorne, C., Fortin, P.R., Fritzler, M., Journal of Scleroderma and Related Disorders, 2017, 10.5301/jsrd.5000227
  • The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients, Choi, M.Y., Clarke, A.E., St Pierre, Y., Hanly, J.G., Urowitz, M.B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Dooley, M.A., Fortin, P., Gladman, D.D., Sanchez-Guerrero, J., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Alarcón, G.S., Manzi, S., Nived, O., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Buyon, J., Mahler, M., Fritzler, M.J., Lupus, 2017, 10.1177/0961203317692437
  • Transancestral mapping and genetic load in systemic lupus erythematosus, Langefeld, C.D., Ainsworth, H.C., Graham, D.S.C., Kelly, J.A., Comeau, M.E., Marion, M.C., Howard, T.D., Ramos, P.S., Croker, J.A., Morris, D.L., Sandling, J.K., Almlöf, J.C., Acevedo-Vásquez, E.M., Alarcón, G.S., Babini, A.M., Baca, V., Bengtsson, A.A., Berbotto, G.A., Bijl, M., Brown, E.E., Brunner, H.I., Cardiel, M.H., Catoggio, L., Cervera, R., Cucho-Venegas, J.M., Dahlqvist, S.R., D'Alfonso, S., Da Silva, B.M., De La RúaFigueroa, I., Doria, A., Edberg, J.C., Endreffy, E., Esquivel-Valerio, J.A., Fortin, P.R., Freedman, B.I., Frostegård, J., Garcýá, M.A., De La Torre, I.G., Gilkeson, G.S., Gladman, D.D., Gunnarsson, I., Guthridge, J.M., Huggins, J.L., James, J.A., Kallenberg, C.G.M., Kamen, D.L., Karp, D.R., Kaufman, K.M., Kottyan, L.C., Kovács, L., Laustrup, H., Lauwerys, B.R., Li, Q.-Z., Maradiaga-Ceceną, M.A., Martín, J., McCune, J.M., McWilliams, D.R., Merrill, J.T., Miranda, P., Moctezuma, J.F., Nath, S.K., Niewold, T.B., Orozco, L., Ortego-Centeno, N., Petri, M., Pineau, C.A., Pons-Estel, B.A., Pope, J., Raj, P., Ramsey-Goldman, R., Reveille, J.D., Russell, L.P., Sabio, J.M., Aguilar-Salinas, C.A., Scherbarth, H.R., Scorza, R., Seldin, M.F., Sjöwall, C., Svenungsson, E., Thompson, S.D., Toloza, S.M.A., Truedsson, L., Tusié-Luna, T., Vasconcelos, C., Vilá, L.M., Wallace, D.J., Weisman, M.H., Wither, J.E., Bhangale, T., Oksenberg, J.R., Rioux, J.D., Gregersen, P.K., Syvänen, A.-C., Rönnblom, L., Criswell, L.A., Jacob, C.O., Sivils, K.L., Tsao, B.P., Schanberg, L.E., Behrens, T.W., Silverman, E.D., Alarcón-Riquelme, M.E., Kimberly, R.P., Harley, J.B., Wakeland, E.K., Graham, R.R., Gaffney, P.M., Vyse, T.J., Nature Communications, 2017, 10.1038/ncomms16021
  • What have multicentre registries across the world taught us about the disease features of systemic sclerosis?, Proudman, S.M., Huq, M., Stevens, W., Wilson, M.E., Sahhar, J., Baron, M., Hudson, M., Pope, J., Allanore, Y., Distler, O., Kowal-Bielecka, O., Matucci-Cerinic, M., H.L. Low, A., Teng, G.G., Law, W.G., Santosa, A., Nikpour, M., Hill, C., Lester, S., Nash, P., Ngian, G.-S., Proudman, S., Rischmueller, M., Roddy, J., Strickland, G., Thakkar, V., Walker, J., Zochling, J., Pope, J., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Hudson, M., Ligier, S., Grodzicky, T., LeClercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Abu-Hakima, M., Rodriguez-Reyna, T.S., Cabral, A.R., Fritzler, M., Avouac, J., Walker, U.A., Guiducci, S., Riemekasten, G., Air, P., Hachulla, E., Valentini, G., Carreira, P.E., Cozzi, F., Gurman, A.B., Braun-Moscovici, Y., Damjanov, N., Ananieva, L.P., Scorza, R., Jimenez, S., Busquets, J., Li, M., Müller-Ladner, U., Maurer, B., Tyndall, A., Lapadula, G., Iannone, F., Becvar, R., Sierakowsky, S., Cutolo, M., Sulli, A., Cuomo, G., Vettori, S., Rednic, S., Nicoara, I., Vlachoyiannopoulos, P., Montecucco, C., Caporali, R., Novak, S., Czirják, L., Varju, C., Chizzolini, C., Kucharz, E.J., Kotulska, A., Kopec-Medrek, M., Widuchowska, M., Rozman, B., Mallia, C., Coleiro, B., Gabrielli, A., Farge, D., Hij, A., Hesselstrand, R., Scheja, A., Wollheim, F., Martinovic, D., Govoni, M., Lo Monaco, A., Hunzelmann, N., Pellerito, R., Bambara, L.M., Caramaschi, P., Black, C., Denton, C., Henes, J., Santamaria, V.O., Heitmann, S., Krasowska, D., Seidel, M., Oleszowsky, M., Burkhardt, H., Himsel, A., Salvador, M.J., Stamenkovic, B., Stankovic, A., Tikly, M., Starovoytova, M.N., Engelhart, M., Strauss, G., Nielsen, H., Damgaard, K., Szücs, G., Mendoza, A.Z., de la Puente Buijdos, C., Giraldo, W.A.S., Midtvedt, Ø., Garen, T., Launay, D., Valesini, G., Riccieri, V., Ionescu, R.M., Opris, D., Groseanu, L., Wigley, F.M., Mihai, C.M., Cornateanu, R.S., Ionitescu, R., Gherghe, A.M., Gorga, M., Dobrota, R., Bojinca, M., Schett, G., Distler, J.H., Meroni, P., Zeni, S., Mouthon, L., De Keyser, F., Smith, V., Cantatore, F.P., Corrado, A., Ullman, S., Iversen, L., Pozzi, M.R., Eyerich, K., Hein, R., Knott, E., Szechinski, J., Wiland, P., Szmyrka-Kaczmarek, M., Sokolik, R., Morgiel, E., Krummel-Lorenz, B., Saar, P., Aringer, M., Günther, C., Anic, B., Baresic, M., Mayer, M., Radominski, S.C., de Souza Müller, C., Azevedo, V.F., Agachi, S., Groppa, L., Chiaburu, L., Russu, E., Zenone, T., Stebbings, S., Highton, J., Stamp, L., Chapman, P., O’Donnell, J., Solanki, K., Doube, A., Veale, D., O’Rourke, M., Loyo, E., Rosato, E., Pisarri, S., Tanaseanu, C.-M., Popescu, M., Dumitrascu, A., Tiglea, I., Chirieac, R., Ancuta, C., Furst, D.E., Kafaja, S., García de la Peña Lefebvre, P., Rubio, S.R., Exposito, M.V., Sibilia, J., Chatelus, E., Gottenberg, J.E., Chifflot, H., Litinsky, I., Venalis, A., Butrimiene, I., Venalis, P., Rugiene, R., Karpec, D., Kerzberg, E., Montoya, F., Cosentino, V., Low, A.H.L., Teng, G., Chan, G., Lim, A.Y.N., Ng, S.C., Journal of Scleroderma and Related Disorders, 2017, 10.5301/jsrd.5000256
  • A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis, Landolt-Marticorena, C., Prokopec, S.D., Morrison, S., Noamani, B., Bonilla, D., Reich, H., Scholey, J., Avila-Casado, C., Fortin, P.R., Boutros, P.C., Wither, J., Arthritis Research and Therapy, 2016, 10.1186/s13075-016-1120-0
  • A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach, Hanly, J.G., Su, L., Urowitz, M.B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Clarke, A.E., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Dooley, M.A., Fortin, P., Gladman, D.D., Sanchez-Guerrero, J., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Alarcón, G.S., Fessler, B.J., Manzi, S., Nived, O., Sturfelt, G.K., Zoma, A.A., van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Theriault, C., Farewell, V., Arthritis and Rheumatology, 2016, 10.1002/art.39674
  • Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study, Baron, M., Pope, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Ligier, S., Grodzicky, T., LeClercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Abu-Hakima, M., Rodriguez-Reyna, T.S., Cabral-Castaneda, A.R., Fritzler, M.J., Wang, M., Hudson, M., Rheumatology (United Kingdom), 2016, 10.1093/rheumatology/kew313
  • Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort, Urowitz, M.B., Gladman, D.D., Anderson, N.M., Su, J., Romero-Diaz, J., Bae, S.C., Fortin, P.R., Sanchez-Guerrero, J., Clarke, A., Bernatsky, S., Gordon, C., Hanly, J.G., Wallace, D.J., Isenberg, D., Rahman, A., Merrill, J., Ginzler, E., Alarcón, G.S., Fessler, B.F., Petri, M., Bruce, I.N., Khamashta, M., Aranow, C., Dooley, M., Manzi, S., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Steinsson, K., Zoma, A., Ruiz-Irastorza, G., Lim, S., Kalunian, K.C., Inanç, M., Van Vollenhoven, R., Ramos-Casals, M., Kamen, D.L., Jacobsen, S., Peschken, C., Askanase, A., Stoll, T., Lupus Science and Medicine, 2016, 10.1136/lupus-2015-000143
  • Connective tissue diseases: Mitochondria drive NETosis and inflammation in SLE, Boilard, E., Fortin, P.R., Nature Reviews Rheumatology, 2016, 10.1038/nrrheum.2016.24
  • Development and Validation of the Body Concealment Scale for Scleroderma, Jewett, L.R., Malcarne, V.L., Kwakkenbos, L., Harcourt, D., Rumsey, N., Körner, A., Steele, R.J., Hudson, M., Baron, M., Haythornthwaite, J.A., Heinberg, L., Wigley, F.M., Thombs, B.D., Pope, J., Masetto, D.A., Sutton, E., Khalidi, N.A., Robinson, D., Jones, N., Kaminska, E., Docherty, P., Mathieu, J.-P., Ligier, S., Grodzicky, T., Mittoo, S., LeClercq, S., Thorne, C., Fortin, P., Arthritis Care and Research, 2016, 10.1002/acr.22819
  • Distinct subtypes of microparticle-containing immune complexes are associated with disease activity, damage, and carotid intima-media thickness in systemic lupus erythematosus, Fortin, P.R., Cloutier, N., Bissonnette, V., Aghdassi, E., Eder, L., Simonyan, D., Laflamme, N., Boilard, E., Journal of Rheumatology, 2016, 10.3899/jrheum.160050
  • Examination of the association of sex and race/ethnicity with appearance concerns: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study, Jewett, L.R., Kwakkenbos, L., Carrier, M.-E., Malcarne, V.L., Bartlett, S.J., Furst, D.E., Gottesman, K., Mayes, M.D., Assassi, S., Harcourt, D., Williamson, H., Johnson, S.R., Körner, A., Steen, V., Fox, R.S., Gholizadeh, S., Mills, S.D., Molnar, J.C., Rice, D.B., Thombs, B.D., Baron, M., van den Hoogen, F., Khanna, D., Mouthon, L., Nielson, W.R., Poiraudeau, S., Riggs, R., Sauve, M., Wigley, F., Boutron, I., Maia, A.C., El-Baalbaki, G., Ells, C., van den Ende, C., Fligelstone, K., Fortune, C., Frech, T., Godard, D., Harel, D., Hudson, M., Impens, A., Jang, Y., Kennedy, A.T., Larche, M., Leite, C., Marra, C., Nielsen, K., Poole, J.L., Pope, J., Portales, A., Reyna, T.S.R., Schouffoer, A.A., Steele, R.J., Suarez-Almazor, M.E., Welling, J., Wong-Rieger, D., Albert, A., Arsenault, G., Bissonnette, L., Boire, G., Bruns, A., Carreira, P., Chung, L., Dagenais, P., Denton, C.P., Domsic, R., Dunne, J.V., Fortin, P., Gill, A., Gordon, J., Gyger, G., Herrick, A.L., Manning, J., Hinchcliff, M., Ikic, A., Jones, N., Fernandes, A.J.B., Kafaja, S., Khalidi, N., Korman, B., Liang, P., Masetto, A., Robinson, D., Roux, S., Schiopu, E., Smith, D., Spiera, R., Sutton, E., Thorne, C., Varga, J., Wilcox, P., Delisle, V.C., Fedoruk, C., Levis, B., Milette, K., Pepin, M.R., Persmann, J., Clinical and Experimental Rheumatology, 2016
  • Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces, Bernatsky, S., Smargiassi, A., Barnabe, C., Svenson, L.W., Brand, A., Martin, R.V., Hudson, M., Clarke, A.E., Fortin, P.R., van Donkelaar, A., Edworthy, S., Bélisle, P., Joseph, L., Environmental Research, 2016, 10.1016/j.envres.2015.12.021
  • Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy: A systematic review, Leclair, V., Regardt, M., Wojcik, S., Hudson, M., Baron, M., Genge, A., O'Ferrall, E., Vinet, E., Gyger, G., Fortin, P.R., Fritzler, M., PLoS ONE, 2016, 10.1371/journal.pone.0160753
  • Subsets in systemic sclerosis: One size does not fit all, Leclair, V., Hudson, M., Proudman, S.M., Stevens, W.M., Fritzler, M.J., Wang, M., Pope, J., Baron, M., Markland, J., Robinson, D., Khalidi, N., Masetto, A., Sutton, E., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Rodriguez-Reyna, T.S., Nikpour, M., Sahhar, J., Zochling, J., Roddy, J., Walker, J., Youssef, P., Journal of Scleroderma and Related Disorders, 2016, 10.5301/jsrd.5000212
  • The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study, Racine, M., Hudson, M., Baron, M., Nielson, W.R., Pope, J., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masseto, A., Sutton, E., Mathieu, J.-P., Ligier, S., Grodzicky, T., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Journal of Pain and Symptom Management, 2016, 10.1016/j.jpainsymman.2015.12.314
  • The longterm effect of early intensive treatment of seniors with rheumatoid arthritis: A comparison of 2 population-based cohort studies on time to joint replacement surgery, Widdifield, J., Moura, C.S., Wang, Y., Abrahamowicz, M., Michael Paterson, J., Huang, A., Beauchamp, M.-E., Boire, G., Fortin, P.R., Bessette, L., Bombardier, C., Hanly, J.G., Feldman, D., Bernatsky, S., Journal of Rheumatology, 2016, 10.3899/jrheum.151156
  • Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study, Levis, B., Rice, D.B., Kwakkenbos, L., Steele, R.J., Hagedoorn, M., Hudson, M., Baron, M., Thombs, B.D., Pope, J., Masetto, D.A., Sutton, E., Khalidi, N.A., Robinson, D., Jones, N., Kaminska, E., Docherty, P., Mathieu, J.-P., Ligier, S., Grodzicky, T., Mittoo, S., LeClercq, S., Thorne, C., Fortin, P., Arthritis Care and Research, 2016, 10.1002/acr.22802
  • Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study, Levis, A.W., Harel, D., Kwakkenbos, L., Carrier, M.-E., Mouthon, L., Poiraudeau, S., Bartlett, S.J., Khanna, D., Malcarne, V.L., Sauve, M., van den Ende, C.H.M., Poole, J.L., Schouffoer, A.A., Welling, J., Thombs, B.D., Baron, M., Ells, C., Jang, Y., Steele, R.J., Furst, D., Kafaja, S., Gottesman, K., van den Hoogen, F., Mayes, M.D., Assassi, S., Nielson, W.R., Riggs, R., Wigley, F., Boutron, I., Maia, A.C., Leite, C., El-Baalbaki, G., Persmann, J., Fligelstone, K., Fortune, C., Nielsen, K., Frech, T., Godard, D., Hudson, M., Gyger, G., Delisle, V.C., Jewitt, L.R., Levis, B., Milette, K., Impens, A., Johnson, S.R., Kennedy, A.T., Larche, M., Khalidi, N., Marra, C., Pope, J., Portales, A., Reyna, T.S.R., Suarez-Almazor, M.E., Wong-Rieger, D., Albert, A., Fortin, P., Ikic, A., Arsenault, G., Bissonnette, L., Boire, G., Bruns, A., Dagenais, P., Fernandes, A.J.D.B., Liang, P., Masetto, A., Roux, S., Carreira, P., Chung, L., Denton, C., Gill, A., Domsic, R., Dunne, J.V., Wilcox, P., Gordon, J., Spiera, R., Herrick, A.L., Hinchcliff, M., Korman, B., Varga, J., Jones, N., Manning, J., Robinson, D., Schiopu, E., Smith, D., Steen, V., Sutton, E., Thorne, C., Fedoruk, C., Pepin, M.R., Fox, R.S., Gholizadeh, S., Mills, S.D., Arthritis Care and Research, 2016, 10.1002/acr.22893
  • Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study, Riehm, K.E., Kwakkenbos, L., Carrier, M.-E., Bartlett, S.J., Malcarne, V.L., Mouthon, L., Nielson, W.R., Poiraudeau, S., Nielsen, K., Baron, M., Frech, T., Hudson, M., Pope, J., Sauve, M., Suarez-Almazor, M.E., Wigley, F.M., Thombs, B.D., Furst, D., Gottesman, K., Mayes, M.D., Riggs, R., van den Hoogen, F., Assassi, S., Boutron, I., Costa Maia, A., El-Baalbaki, G., Ells, C., van den Ende, C.H.M., Fligelstone, K., Fortune, C., Godard, D., Harel, D., Impens, A., Jang, Y., Johnson, S.R., Tyrell Kennedy, A., Körner, A., Leite, C., Marra, C., Poole, J.L., Portales, A., Sofia Rodriguez Reyna, T., Schouffoer, A.A., Steele, R.J., Welling, J., Wong-Rieger, D., Albert, A., Arsenault, G., Carreira, P., Chung, L., Dagenais, P., Denton, C., Domsic, R., Dunne, J.V., Fortin, P., Gordon, J., Gyger, G., Herrick, A., Hinchcliff, M., Jones, N., Fernandes, A.J.D.B., Kafaja, S., Khalidi, N., Korman, B., Larche, M., Liang, P., Masetto, A., Robinson, D., Roux, S., Schiopu, E., Smith, D., Spiera, R., Steen, V., Thorne, C., Varga, J., Wilcox, P., Delisle, V.C., Fox, R.S., Gholizadeh, S., Fedoruk, C., Jewett, L.R., Levis, B., Milette, K., Pepin, M.R., Mills, S.D., Arthritis Care and Research, 2016, 10.1002/acr.22807
  • Vasculitis and malignancy, Fortin, P.R., Inflammatory Diseases of Blood Vessels, 2016
  • 2013 american college of rheumatology/european league against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: Data from the canadian scleroderma research group, Alhajeri, H., Hudson, M., Fritzler, M., Pope, J., Tatibouet, S., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Ligier, S., Grodzicky, T., Leclercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Baron, M., Arthritis Care and Research, 2015, 10.1002/acr.22451
  • Anti-C1q antibodies in systemic lupus erythematosus, Orbai, A.-M., Truedsson, L., Sturfelt, G., Nived, O., Fang, H., Alarcón, G.S., Gordon, C., Merrill, J.T., Fortin, P.R., Bruce, I.N., Isenberg, D.A., Wallace, D.J., Ramsey-Goldman, R., Bae, S.-C., Hanly, J.G., Sanchez-Guerrero, J., Clarke, A.E., Aranow, C.B., Manzi, S., Urowitz, M.B., Gladman, D.D., Kalunian, K.C., Costner, M.I., Werth, V.P., Zoma, A., Bernatsky, S., Ruiz-Irastorza, G., Khamashta, M.A., Jacobsen, S., Buyon, J.P., Maddison, P., Dooley, M.A., Van Vollenhoven, R.F., Ginzler, E., Stoll, T., Peschken, C., Jorizzo, J.L., Callen, J.P., Lim, S.S., Fessler, B.J., Inanc, M., Kamen, D.L., Rahman, A., Steinsson, K., Franks, A.G., Sigler, L., Hameed, S., Pham, N., Brey, R., Weisman, M.H., McGwin, G., Magder, L.S., Petri, M., Lupus, 2015, 10.1177/0961203314547791
  • Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus, Li, T., Prokopec, S.D., Morrison, S., Lou, W., Reich, H., Gladman, D., Urowitz, M., Scholey, J., Fortin, P.R., Boutros, P.C., Wither, J., Landolt-Marticorena, C., Rheumatology (Oxford, England), 2015, 10.1093/rheumatology/keu326
  • Approaches for estimating minimal clinically important differences in systemic lupus erythematosus, Rai, S.K., Yazdany, J., Fortin, P.R., Aviña-Zubieta, J.A., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0658-6
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis, Ikic, A., Beaudoin, C., Brown, J.P., Bessette, L., Fortin, P.R., Michou, L., Joint Bone Spine, 2015, 10.1016/j.jbspin.2014.12.005
  • Assessment of the educational impact of an information leaflet on the knowledge of complications in systemic sclerosis,Évaluation de l'impact d'une brochure d'information sur la connaissance des complications dans la sclérodermie systémique, Ikic, A., Beaudoin, C., Brown, J.P., Bessette, L., Fortin, P.R., Michou, L., Revue du Rhumatisme (Edition Francaise), 2015, 10.1016/j.rhum.2015.04.001
  • Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects, Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., Assassi, S., Mayes, M.D., Tatibouet, S., Wang, M., Pope, J., Baron, M., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Ligier, S., Grodzicky, T., LeClercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Fritzler, M.J., Hill, C., Lester, S., Nash, P., Roddy, J., Patterson, K., Rischmueller, M., Sahhar, J., Zochling, J., McNearney, T.A., Salazar, G., Autoimmunity, 2015, 10.3109/08916934.2015.1077231
  • Early medication use in new-onset rheumatoid arthritis may delay joint replacement: Results of a large population-based study, Moura, C.S., Abrahamowicz, M., Beauchamp, M.-E., Lacaille, D., Wang, Y., Boire, G., Fortin, P.R., Bessette, L., Bombardier, C., Widdifield, J., Hanly, J.G., Feldman, D., Maksymowych, W., Peschken, C., Barnabe, C., Edworthy, S., Bernatsky, S., Arthritis Research and Therapy, 2015, 10.1186/s13075-015-0713-3
  • Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort, Bourré-Tessier, J., Urowitz, M.B., Clarke, A.E., Bernatsky, S., Krantz, M.J., Huynh, T., Joseph, L., Belisle, P., Bae, S.-C., Hanly, J.G., Wallace, D.J., Gordon, C., Isenberg, D., Rahman, A., Gladman, D.D., Fortin, P.R., Merrill, J.T., Romero-Diaz, J., Sanchez-Guerrero, J., Fessler, B., Alarcón, G.S., Steinsson, K., Bruce, I.N., Ginzler, E., Dooley, M.A., Nived, O., Sturfelt, G., Kalunian, K., Ramos-Casals, M., Petri, M., Zoma, A., Pineau, C.A., Arthritis Care and Research, 2015, 10.1002/acr.22370
  • Factors associated with damage accrual in patients with systemic lupus erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort, Bruce, I.N., O'Keeffe, A.G., Farewell, V., Hanly, J.G., Manzi, S., Su, L., Gladman, D.D., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Wallace, D.J., Clarke, A.E., Bernatsky, S., Ginzler, E.M., Isenberg, D.A., Rahman, A., Merrill, J.T., Alarcón, G.S., Fessler, B.J., Fortin, P.R., Petri, M., Steinsson, K., Dooley, M.A., Khamashta, M.A., Ramsey-Goldman, R., Zoma, A.A., Sturfelt, G.K., Nived, O., Aranow, C., Mackay, M., Ramos-Casals, M., Van Vollenhoven, R.F., Kalunian, K.C., Ruiz-Irastorza, G., Lim, S., Kamen, D.L., Peschken, C.A., Inanc, M., Urowitz, M.B., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2013-205171
  • Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta, Bernatsky, S., Smargiassi, A., Johnson, M., Kaplan, G.G., Barnabe, C., Svenson, L., Brand, A., Bertazzon, S., Hudson, M., Clarke, A.E., Fortin, P.R., Edworthy, S., Bélisle, P., Joseph, L., Environmental Research, 2015, 10.1016/j.envres.2015.05.007
  • Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort, Parker, B., Urowitz, M.B., Gladman, D.D., Lunt, M., Donn, R., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Wallace, D.J., Clarke, A.E., Bernatsky, S., Ginzler, E.M., Isenberg, D.A., Rahman, A., Merrill, J.T., Alarcón, G.S., Fessler, B.J., Fortin, P.R., Hanly, J.G., Petri, M., Steinsson, K., Dooley, M.A., Manzi, S., Khamashta, M.A., Ramsey-Goldman, R., Zoma, A.A., Sturfelt, G.K., Nived, O., Aranow, C., Mackay, M., Ramos-Casals, M., Van Vollenhoven, R.F., Kalunian, K.C., Ruiz-Irastorza, G., Lim, S.S., Kamen, D.L., Peschken, C.A., Inanc, M., Bruce, I.N., Annals of the Rheumatic Diseases, 2015, 10.1136/annrheumdis-2013-203933
  • Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus, Chang, N.-H., Li, T.T., Kim, J.J., Landolt-Marticorena, C., Fortin, P.R., Gladman, D.D., Urowitz, M.B., Wither, J.E., Journal of Autoimmunity, 2015, 10.1016/j.jaut.2015.01.009
  • Job accommodations availability and utilization among people with lupus: An examination of workplace activity limitations and work context factors, Al Dhanhani, A.M., Gignac, M.A.M., Beaton, D.E., Su, J., Fortin, P.R., Arthritis Care and Research, 2015, 10.1002/acr.22662
  • Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival, Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., Assassi, S., Mayes, M.D., Wang, M., Baron, M., Fritzler, M.J., Pope, J., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Ligier, S., Grodzicky, T., LeClercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Rodriguez-Reyna, T.S., Cabral, A.R., Fritzler, M.J., Hill, C., Lester, S., Nash, P., Roddy, J., Patterson, K., Proudman, S., Rischmueller, M., Sahhar, J., Stevens, W., Walker, J., Zochling, J., Assassi, S., Mayes, M.D., McNearney, T.A., Salazar, G., Clinical and Experimental Rheumatology, 2015
  • Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study, Hanly, J.G., Su, L., Urowitz, M.B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Clarke, A.E., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Dooley, M.A., Fortin, P., Gladman, D.D., Sanchez-Guerrero, J., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Alarcón, G.S., Fessler, B.J., Manzi, S., Nived, O., Sturfelt, G.K., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Theriault, C., Thompson, K., Farewell, V., Arthritis and Rheumatology, 2015, 10.1002/art.39111
  • The frequency and outcome of lupus nephritis: Results from an international inception cohort study, Hanly, J.G., O'Keeffe, A.G., Su, L., Urowitz, M.B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Clarke, A.E., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Fortin, P., Gladman, D.D., Sanchez-Guerrero, J., Petri, M., Bruce, I.N., Dooley, M.A., Ramsey-Goldman, R., Aranow, C., Alarcón, G.S., Fessler, B.J., Steinsson, K., Nived, O., Sturfelt, G.K., Manzi, S., Khamashta, M.A., Van Vollenhoven, R.F., Zoma, A.A., Ramos-Casals, M., Ruiz-Irastorza, G., Sam Lim, S., Stoll, T., Inanc, M., Kalunian, K.C., Kamen, D.L., Maddison, P., Peschken, C.A., Jacobsen, S., Askanase, A., Theriault, C., Thompson, K., Farewell, V., Rheumatology (United Kingdom), 2015, 10.1093/rheumatology/kev311
  • Thinking outside the box-The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect, Srivastava, N., Hudson, M., Tatibouet, S., Wang, M., Baron, M., Fritzler, M.J., Pope, J., Markland, J., Robinson, D., Jones, N., Khalidi, N., Docherty, P., Kaminska, E., Masetto, A., Sutton, E., Mathieu, J.-P., Ligier, S., Grodzicky, T., LeClercq, S., Thorne, C., Gyger, G., Smith, D., Fortin, P.R., Larché, M., Fritzler, M., Seminars in Arthritis and Rheumatism, 2015, 10.1016/j.semarthrit.2015.04.009
  • Unpacking early work experiences of young adults with rheumatic disease: An examination of absenteeism, job disruptions, and productivity loss, Jetha, A., Badley, E., Beaton, D., Fortin, P.R., Shiff, N.J., Gignac, M.A.M., Arthritis Care and Research, 2015, 10.1002/acr.22601
  • 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: Data from a large international inception cohort, Lertratanakul, A., Wu, P., Dyer, A., Urowitz, M., Gladman, D., Fortin, P., Bae, S.-C., Gordon, C., Clarke, A., Bernatsky, S., Hanly, J.G., Isenberg, D., Rahman, A., Merrill, J., Wallace, D.J., Ginzler, E., Khamashta, M., Bruce, I., Nived, O., Sturfelt, G., Steinsson, K., Manzi, S., Dooley, M.A., Kalunian, K., Petri, M., Aranow, C., Font, J., Van Vollenhoven, R., Stoll, T., Ramsey-Goldman, R., Arthritis Care and Research, 2014, 10.1002/acr.22291
  • American college of rheumatology criteria at inception, and accrual over 5 years in the slicc inception cohort, Urowitz, M.B., Gladman, D.D., Ibañez, D., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Bae, S.-C., Clarke, A.E., Bernatsky, S., Fortin, P.R., Hanly, J.G., Isenberg, D., Rahman, A., Wallace, D.J., Ginzler, E., Petri, M., Bruce, I.N., Merrill, J.T., Nived, O., Sturfelt, G., Dooley, M.A., Alarcón, G.S., Fessler, B., Steinsson, K., Ramsey-Goldman, R., Zoma, A., Khamashta, M., Manzi, S., Van Vollenhoven, R., Ramos-Casals, M., Aranow, C., Stoll, T., Journal of Rheumatology, 2014, 10.3899/jrheum.130704
  • Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: Results from a multiethnic multicenter canadian cohort, Levy, D.M., Peschken, C.A., Tucker, L.B., Chédeville, G., Huber, A.M., Pope, J.E., Silverman, E.D., Petty, R., Cabral, D., Houghton, K., Morishita, K., Campillo, S., Duffy, K., Scuccimarri, R., Lang, B., Ramsey, S., Warner, A., Ng, L., Fortin, P., Urowitz, M., Gladman, D., Albert, L., Carette, S., Inman, R., McKenzie, T., Clarke, A., Pineau, C., Bernatsky, S., Tobaly, M., Santopietro, T., Smith, C.D., Simpson, S., Smith, K., Zummer, M., Ferland, D., Arbillaga, H., Wehlage, A., Hudson, M., Baron, M., Berkson, L., Bernstein, J., Hanly, J., Hewitt, S., Ouimet, J., Hitchon, C., Craig, A., Moyen, M., Arthritis Care and Research, 2014, 10.1002/acr.22363
  • Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus, Urowitz, M., Gladman, D.D., Ibañez, D., Sanchez-Guerrero, J., Bae, S.C., Gordon, C., Fortin, P.R., Clarke, A., Bernatsky, S., Hanly, J.G., Wallace, D.J., Isenberg, D., Rahman, A., Merrill, J., Ginzler, E., Alarcõn, G.S., Fessler, B., Khamashta, M., Steinsson, K., Petri, M., Dooley, M., Bruce, I.N., Manzi, S., Sturfelt, G., Nived, O., Ramsey-Goldman, R., Zoma, A., Maddison, P., Kalunian, K., Van Vollenhoven, R., Aranow, C., Romero Diaz, J., Stoll, T., Arthritis Care and Research, 2014, 10.1002/acr.22299
  • Effect of menopause on the modified Rodnan skin score in systemic sclerosis, Vinet, T., Bernatsky, S., Hudson, M., Pineau, C.A., Baron, M., Pope, J., Markland, J., Robinson, D., Jones, N., Khalidi, N., Larché, M., Docherty, P., Kaminska, E., LeClercq, S., Masetto, A., Sutton, E., Mathieu, J.-P., Ligier, S., Grodzicky, T., Gyger, G., Thorne, C., Smith, D., Fortin, P.R., Fritzler, M., Arthritis Research and Therapy, 2014, 10.1186/ar4587
  • Erratum: Incorrect values for intractable and cluster headaches at enrollment shown in figure 1 and incorrect prevalence of headache at ten years in text of the article by hanly et al (Arthritis and Rheumatology (2013)), Hanly, J.G., Urowitz, M.B., O'Keeffe, A.G., Gordon, C., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Clarke, A.E., Bernatsky, S., Wallace, D.J., Ginzler, E.M., Isenberg, D.A., Rahman, A., Merrill, J.T., Petri, M., Fortin, P.R., Gladman, D.D., Fessler, B.J., Alarcõn, G.S., Bruce, I.N., Dooley, M.A., Steinsson, K., Khamashta, M.A., Ramsey-Goldman, R., Manzi, S., Sturfelt, G.K., Nived, O., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Kalunian, K.C., Lim, S.S., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Theriault, C., Thompson, K., Farewell, V., Arthritis and Rheumatology, 2014, 10.1002/art.38707
  • Lymphoma risk in systemic lupus: Effects of disease activity versus treatment, Bernatsky, S., Ramsey-Goldman, R., Joseph, L., Boivin, J.-F., Costenbader, K.H., Urowitz, M.B., Gladman, D.D., Fortin, P.R., Nived, O., Petri, M.A., Jacobsen, S., Manzi, S., Ginzler, E.M., Isenberg, D., Rahman, A., Gordon, C., Ruiz-Irastorza, G., Yelin, E., Bae, S.-C., Wallace, D.J., Peschken, C.A., Dooley, M.A., Edworthy, S.M., Aranow, C., Kamen, D.L., Romero-Diaz, J., Askanase, A., Witte, T., Barr, S.G., Criswell, L.A., Sturfelt, G.K., Blanco, I., Feldman, C.H., Dreyer, L., Patel, N.M., Pierre, Y.St., Clarke, A.E., Annals of the Rheumatic Diseases, 2014, 10.1136/annrheumdis-2012-202099
  • Rheumatoid arthritis prevalence in Quebec, Bernatsky, S., Dekis, A., Hudson, M., Pineau, C.A., Boire, G., Fortin, P.R., Bessette, L., Jean, S., Chetaille, A.L., Belisle, P., Bergeron, L., Feldman, D.E., Joseph, L., BMC Research Notes, 2014, 10.1186/1756-0500-7-937
  • Systemic autoimmune rheumatic disease prevalence in Canada: Updated analyses across 7 provinces, Broten, L., Aviña-Zubieta, J.A., Lacaille, D., Joseph, L., Hanly, J.G., Lix, L., O'Donnell, S., Barnabe, C., Fortin, P.R., Hudson, M., Jean, S., Peschken, C., Edworthy, S.M., Svenson, L., Pineau, C.A., Clarke, A.E., Smith, M., Bélisle, P., Badley, E.M., Bergeron, L., Bernatsky, S., Journal of Rheumatology, 2014, 10.3899/jrheum.130667
  • The needs of persons with lupus and health care providers: A qualitative study aimed toward the development of the Lupus Interactive Navigator™, Neville, C., Costa, D.D., Mill, C., Rochon, M., Aviña-Zubieta, J.A., Pineau, C.A., Eng, D., Fortin, P.R., Lupus, 2014, 10.1177/0961203313517154
  • Transitioning to employment with a rheumatic disease: The role of independence, overprotection, and social support, Jetha, A., Badley, E., Beaton, D., Fortin, P.R., Shiff, N.J., Rosenberg, A.M., Tucker, L.B., Mosher, D.P., Gignac, M.A.M., Journal of Rheumatology, 2014, 10.3899/jrheum.140419
  • Work factors are associated with workplace activity limitations in systemic lupus erythematosus, Dhanhani, A.M., Gignac, M.A., Beaton, D.E., Su, J., Fortin, P.R., Rheumatology (United Kingdom), 2014, 10.1093/rheumatology/keu242
  • A hot spot for systemic lupus erythematosus, but not for psoriatic arthritis, identified by spatial analysis suggests an interaction between ethnicity and place of residence, Al-Maini, M., Jeyalingam, T., Brown, P., Lee, J.J.Y., Li, L., Su, J., Gladman, D.D., Fortin, P.R., Arthritis and Rheumatism, 2013, 10.1002/art.37897
  • Association of smoking with cutaneous manifestations in systemic lupus erythematosus, Bourré-Tessier, J., Peschken, C.A., Bernatsky, S., Joseph, L., Clarke, A.E., Fortin, P.R., Hitchon, C., Mittoo, S., Smith, C.D., Zummer, M., Pope, J., Tucker, L., Hudson, M., Arbillaga, H., Esdaile, J., Silverman, E., Chédeville, G., Huber, A.M., Belisle, P., Pineau, C.A., Arthritis Care and Research, 2013, 10.1002/acr.21966
  • Breast cancer in systemic lupus erythematosus, Tessier Cloutier, B., Clarke, A.E., Ramsey-Goldman, R., Wang, Y., Foulkes, W., Gordon, C., Hansen, J.E., Yelin, E., Urowitz, M.B., Gladman, D., Fortin, P.R., Wallace, D.J., Petri, M., Manzi, S., Ginzler, E.M., Labrecque, J., Edworthy, S., Dooley, M.A., Senécal, J.L., Peschken, C.A., Bae, S.C., Isenberg, D., Rahman, A., Ruiz-Irastorza, G., Hanly, J.G., Jacobsen, S., Nived, O., Witte, T., Criswell, L.A., Barr, S.G., Dreyer, L., Sturfelt, G., Bernatsky, S., Oncology (Switzerland), 2013, 10.1159/000353138
  • Cancer risk in systemic lupus: An updated international multi-centre cohort study, Bernatsky, S., Ramsey-Goldman, R., Labrecque, J., Joseph, L., Boivin, J.-F., Petri, M., Zoma, A., Manzi, S., Urowitz, M.B., Gladman, D., Fortin, P.R., Ginzler, E., Yelin, E., Bae, S.-C., Wallace, D.J., Edworthy, S., Jacobsen, S., Gordon, C., Dooley, M.A., Peschken, C.A., Hanly, J.G., Alarcón, G.S., Nived, O., Ruiz-Irastorza, G., Isenberg, D., Rahman, A., Witte, T., Aranow, C., Kamen, D.L., Steinsson, K., Askanase, A., Barr, S., Criswell, L.A., Sturfelt, G., Patel, N.M., Senécal, J.-L., Zummer, M., Pope, J.E., Ensworth, S., El-Gabalawy, H., McCarthy, T., Dreyer, L., Sibley, J., St. Pierre, Y., Clarke, A.E., Journal of Autoimmunity, 2013, 10.1016/j.jaut.2012.12.009
  • Clinical associations of the metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort, Parker, B., Urowitz, M.B., Gladman, D.D., Lunt, M., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Gordon, C., Wallace, D.J., Clarke, A.E., Bernatsky, S., Ginzler, E.M., Isenberg, D.A., Rahman, A., Merrill, J.T., Alarcón, G.S., Fessler, B.J., Fortin, P.R., Hanly, J.G., Petri, M., Steinsson, K., Dooley, M.-A., Manzi, S., Khamashta, M.A., Ramsey-Goldman, R., Zoma, A.A., Sturfelt, G.K., Nived, O., Aranow, C., MacKay, M., Ramos-Casals, M., Van Vollenhoven, R.F., Kalunian, K.C., Ruiz-Irastorza, G., Lim, S., Kamen, D.L., Peschken, C.A., Inanc, M., Bruce, I.N., Annals of the Rheumatic Diseases, 2013, 10.1136/annrheumdis-2012-202106
  • Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: A qualitative study, Feldman, C.H., Bermas, B.L., Zibit, M., Fraser, P., Todd, D.J., Fortin, P.R., Massarotti, E., Costenbader, K.H., Lupus, 2013, 10.1177/0961203312463979
  • Headache in systemic lupus erythematosus: Results from a prospective, international inception cohort study, Hanly, J.G., Urowitz, M.B., O'Keeffe, A.G., Gordon, C., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Clarke, A.E., Bernatsky, S., Wallace, D.J., Ginzler, E.M., Isenberg, D.A., Rahman, A., Merrill, J.T., Petri, M., Fortin, P.R., Gladman, D.D., Fessler, B.J., Alarcõn, G.S., Bruce, I.N., Dooley, M.A., Steinsson, K., Khamashta, M.A., Ramsey-Goldman, R., Manzi, S., Sturfelt, G.K., Nived, O., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Kalunian, K.C., Lim, S.S., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Theriault, C., Thompson, K., Farewell, V., Arthritis and Rheumatism, 2013, 10.1002/art.38106
  • Non-lymphoma hematological malignancies in systemic lupus erythematosus, Lu, M., Bernatsky, S., Ramsey-Goldman, R., Petri, M., Manzi, S., Urowitz, M.B., Gladman, D., Fortin, P.R., Ginzler, E.M., Yelin, E., Bae, S.-C., Wallace, D.J., Jacobsen, S., Dooley, M.A., Peschken, C.A., Alarcón, G.S., Nived, O., Gottesman, L., Criswell, L.A., Sturfelt, G., Dreyer, L., Lee, J.L., Clarke, A.E., Oncology (Switzerland), 2013, 10.1159/000350165
  • Systematic review of validation studies of the use of administrative data to identify serious infections, Barber, C., Lacaille, D., Fortin, P.R., Arthritis Care and Research, 2013, 10.1002/acr.21959
  • The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus, Akhavan, P.S., Su, J., Lou, W., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Journal of Rheumatology, 2013, 10.3899/jrheum.120572
  • The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort, Lee, J., Peschken, C.A., Muangchan, C., Silverman, E., Pineau, C., Smith, C.D., Arbillaga, H., Zummer, M., Clarke, A., Bernatsky, S., Hudson, M., Hitchon, C., Fortin, P.R., Pope, J.E., Lupus, 2013, 10.1177/0961203313505689
  • A functional marked point process model for lupus data, Fok, C.C.T., Ramsay, J.O., Abrahamowicz, M., Fortin, P., Canadian Journal of Statistics, 2012, 10.1002/cjs.11136
  • Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus, Petri, M., Orbai, A.-M., Alarcõn, G.S., Gordon, C., Merrill, J.T., Fortin, P.R., Bruce, I.N., Isenberg, D., Wallace, D.J., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Bae, S.-C., Hanly, J.G., Sánchez-Guerrero, J., Clarke, A., Aranow, C., Manzi, S., Urowitz, M., Gladman, D., Kalunian, K., Costner, M., Werth, V.P., Zoma, A., Bernatsky, S., Ruiz-Irastorza, G., Khamashta, M.A., Jacobsen, S., Buyon, J.P., Maddison, P., Dooley, M.A., Van Vollenhoven, R.F., Ginzler, E., Stoll, T., Peschken, C., Jorizzo, J.L., Callen, J.P., Lim, S.S., Fessler, B.J., Inanc, M., Kamen, D.L., Rahman, A., Steinsson, K., Franks Jr., A.G., Sigler, L., Hameed, S., Fang, H., Pham, N., Brey, R., Weisman, M.H., McGwin Jr., G., Magder, L.S., Arthritis and Rheumatism, 2012, 10.1002/art.34473
  • Evaluation of clinical outcomes and renal vascular pathology among patients with lupus, Barber, C., Herzenberg, A., Aghdassi, E., Su, J., Lou, W., Qian, G., Yip, J., Nasr, S.H., Thomas, D., Scholey, J.W., Wither, J., Urowitz, M., Gladman, D., Reich, H., Fortin, P.R., Clinical Journal of the American Society of Nephrology, 2012, 10.2215/CJN.02870311
  • Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort, Urowitz, M.B., Gladman, D.D., Ibañez, D., Fortin, P.R., Bae, S.C., Gordon, C., Clarke, A., Bernatsky, S., Hanly, J.G., Isenberg, D., Rahman, A., Sanchez-Guerrero, J., Wallace, D.J., Ginzler, E., Alarcón, G.S., Merrill, J.T., Bruce, I.N., Sturfelt, G., Nived, O., Steinsson, K., Khamashta, M., Petri, M., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Van Vollenhoven, R.F., Ramos, M., Stoll, T., Zoma, A., Kalunian, K., Aranow, C., Arthritis Care and Research, 2012, 10.1002/acr.20648
  • Longitudinal evolution of risk of coronary heart disease in systemic lupus erythematosus, Karp, I., Abrahamowicz, M., Fortin, P.R., Pilote, L., Neville, C., Pineau, C.A., Esdaile, J.M., Journal of Rheumatology, 2012, 10.3899/jrheum.111127
  • Medication use in systemic lupus erythematosus (Journal of Rheumatology (2010) 38 (271-274)), Bernatsky, S., Peschken, C., Fortin, P.R., Journal of Rheumatology, 2012, 10.3899/jrheum.100414.C1
  • Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort, Borowoy, A.M., Pope, J.E., Silverman, E., Fortin, P.R., Pineau, C., Smith, C.D., Arbillaga, H., Gladman, D., Urowitz, M., Zummer, M., Hudson, M., Tucker, L., Peschken, C., Seminars in Arthritis and Rheumatism, 2012, 10.1016/j.semarthrit.2012.03.011
  • Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus, Huang, D., Aghdassi, E., Su, J., Mosko, J., Hirschfield, G.M., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Journal of Rheumatology, 2012, 10.3899/jrheum.110310
  • Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study, Hanly, J.G., Urowitz, M.B., Su, L., Gordon, C., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., Wallace, D.J., Clarke, A.E., Ginzler, E.M., Merrill, J.T., Isenberg, D.A., Rahman, A., Petri, M., Fortin, P.R., Gladman, D.D., Bruce, I.N., Steinsson, K., Dooley, M.A., Khamashta, M.A., Alarcón, G.S., Fessler, B.J., Ramsey-Goldman, R., Manzi, S., Zoma, A.A., Sturfelt, G.K., Nived, O., Aranow, C., Mackay, M., Ramos-Casals, M., Van Vollenhoven, R.F., Kalunian, K.C., Ruiz-Irastorza, G., Lim, S., Kamen, D.L., Peschken, C.A., Inanc, M., Theriault, C., Thompson, K., Farewell, V., Annals of the Rheumatic Diseases, 2012, 10.1136/annrheumdis-2011-201089
  • Spatial modelling of lupus incidence over 40 years with changes in census areas, Li, Y., Brown, P., Rue, H., Al-Maini, M., Fortin, P., Journal of the Royal Statistical Society. Series C: Applied Statistics, 2012, 10.1111/j.1467-9876.2011.01004.x
  • Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus, Lee, J.J.Y., Aghdassi, E., Cheung, A.M., Morrison, S., Cymet, A., Peeva, V., Neville, C., Hewitt, S., DaCosta, D., Pineau, C., Pope, J., Fortin, P.R., Journal of Rheumatology, 2012, 10.3899/jrheum.111589
  • A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles, Budarf, M.L., Goyette, P., Boucher, G., Lian, J., Graham, R.R., Claudio, J.O., Hudson, T., Gladman, D., Clarke, A.E., Pope, J.E., Peschken, C., Smith, C.D., Hanly, J., Rich, E., Boire, G., Barr, S.G., Zummer, M., Fortin, P.R., Wither, J., Rioux, J.D., Genes and Immunity, 2011, 10.1038/gene.2010.47
  • Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: A pilot study, Aghdassi, E., Ma, D.W.L., Morrison, S., Hillyer, L.M., Clarke, S., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Journal of Parenteral and Enteral Nutrition, 2011, 10.1177/0148607110386378
  • An assessment of disease flare in patients with systemic lupus erythematosus: A comparison of BILAG 2004 and the flare version of SELENA, Isenberg, D.A., Allen, E., Farewell, V., D'Cruz, D., Alarcón, G.S., Aranow, C., Bruce I.n., Dooley, M.A., Fortin, P.R., Ginzler, E.M., Gladman, D.D., Hanly, J.G., Inanc, M., Kalunian, K., Khamashta, M., Merrill, J.T., Nived, O., Petri, M., Ramsey-Goldman, R., Sturfelt, G., Urowitz, M., Wallace, D.J., Gordon, C., Rahman, A., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.132068
  • Association of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies, Dieudé, M., Correa, J.A., Neville, C., Pineau, C., Levine, J.S., Subang, R., Landolt-Marticorena, C., Su, J., Kassis, J., Solymoss, S., Fortin, P.R., Rauch, J., Arthritis and Rheumatism, 2011, 10.1002/art.30411
  • Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus, Hanly, J.G., Urowitz, M.B., Su, L., Bae, S.-C., Gordon, C., Clarke, A., Bernatsky, S., Vasudevan, A., Isenberg, D., Rahman, A., Wallace, D.J., Fortin, P.R., Gladman, D., Romero-Dirz, J., Sanchez-Guerrero, J., Dooley, M.A., Bruce, I., Steinsson, K., Khamashta, M., Manzi, S., Ramsey-Goldman, R., Sturfelt, G., Nived, O., Van Vollenhoven, R., Ramos-Casals, M., Aranow, C., Mackay, M., Kalunian, K., Alarcoń, G.S., Fessler, B.J., Ruiz-Irastorza, G., Petri, M., Lim, S., Kamen, D., Peschken, C., Farewell, V., Thompson, K., Theriault, C., Merrill, J.T., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.148502
  • Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity, Ippolito, A., Wallace, D.J., Gladman, D., Fortin, P.R., Urowitz, M., Werth, V., Costner, M., Gordon, C., Alarcón, G.S., Ramsey-Goldman, R., Maddison, P., Clarke, A., Bernatsky, S., Manzi, S., Bae, S.-C., Merrill, J.T., Ginzler, E., Hanly, J.G., Nived, O., Sturfelt, G., Sanchez-Guerrero, J., Bruce, I., Aranow, C., Isenberg, D., Zoma, A., Magder, L.S., Buyon, J., Kalunian, K., Dooley, M.A., Steinsson, K., Van Vollenhoven, R.F., Stoll, T., Weisman, M., Petri, M., Lupus, 2011, 10.1177/0961203310385738
  • Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus, Zhang, W., Aghdassi, E., Reich, H.N., Su, J., Lou, W., Landolt-Marticorena, C., Gladman, D.D., Urowitz, M.B., Scholey, J., Fortin, P.R., Rheumatology, 2011, 10.1093/rheumatology/keq383
  • Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis, Aghdassi, E., Zhang, W., St.-Pierre, Y., Clarke, A.E., Morrison, S., Peeva, V., Landolt-Marticorena, C., Su, J., Reich, H., Scholey, J., Herzenberg, A., Pope, J.E., Peschken, C., Wither, J.E., Fortin, P.R., Journal of Rheumatology, 2011, 10.3899/jrheum.100482
  • Increased expression of B cell activation factor supports the abnormal expansion of transitional B Cells in systemic lupus erythematosus, Landolt-Marticorena, C., Wither, R., Reich, H., Herzenberg, A., Scholey, J., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Wither, J., Journal of Rheumatology, 2011, 10.3899/jrheum.100214
  • Infections in the lupus patient: Perspectives on prevention, Barber, C., Gold, W.L., Fortin, P.R., Current Opinion in Rheumatology, 2011, 10.1097/BOR.0b013e3283476cd8
  • International consensus for a definition of disease flare in lupus, Ruperto, N., Hanrahan, L.M., Alarcón, G.S., Belmont, H.M., Brey, R.L., Brunetta, P., Buyon, J.P., Costner, M.I., Cronin, M.E., Dooley, M.A., Filocamo, G., Fiorentino, D., Fortin, P.R., Franks, A.G., Gilkeson, G., Ginzler, E., Gordon, C., Grossman, J., Hahn, B., Isenberg, D.A., Kalunian, K.C., Petri, M., Sammaritano, L., Sánchez-Guerrero, J., Sontheimer, R.D., Strand, V., Urowitz, M., Von Feldt, J.M., Werth, V.P., Merrill, J.T., Lupus, 2011, 10.1177/0961203310388445
  • Medication use in systemic lupus erythematosus, Bernatsky, S., Peschken, C., Fortin, P.R., Pineau, C.A., Urowitz, M.B., Gladman, D.D., Pope, J.E., Hudson, M., Zummer, M., Smith, C.D., Arbillaga, H.O., Clarke, A.E., Journal of Rheumatology, 2011, 10.3899/jrheum.100414
  • Molecular markers of injury in kidney biopsy specimens of patients with lupus nephritis, Reich, H.N., Landolt-Marticorena, C., Boutros, P.C., John, R., Wither, J., Fortin, P.R., Yang, S., Scholey, J.W., Herzenberg, A.M., Journal of Molecular Diagnostics, 2011, 10.1016/j.jmoldx.2010.10.005
  • Peripheral Neuropathy in Patients with Systemic Lupus Erythematosus, Florica, B., Aghdassi, E., Su, J., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Seminars in Arthritis and Rheumatism, 2011, 10.1016/j.semarthrit.2011.04.001
  • Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus, Reich, H.N., Gladman, D.D., Urowitz, M.B., Bargman, J.M., Hladunewich, M.A., Lou, W., Fan, S.C.P., Su, J., Herzenberg, A.M., Cattran, D.C., Wither, J., Landolt-Marticorena, C., Scholey, J.W., Fortin, P.R., Kidney International, 2011, 10.1038/ki.2010.525
  • Posterior Reversible Encephalopathy Syndrome: An Emerging Disease Manifestation in Systemic Lupus Erythematosus, Barber, C.E., Leclerc, R., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Seminars in Arthritis and Rheumatism, 2011, 10.1016/j.semarthrit.2011.07.001
  • SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus, Hanly, J.G., Urowitz, M.B., Jackson, D., Bae, S.C., Gordon, C., Wallace, D.J., Clarke, A., Bernatsky, S., Vasudevan, A., Isenberg, D., Rahman, A., Sanchez-Guerrero, J., Romero-Diaz, J., Merrill, J.T., Fortin, P.R., Gladman, D.D., Bruce, I.N., Steinsson, K., Khamashta, M., Alarcón, G.S., Fessler, B., Petri, M., Manzi, S., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Dooley, M.A., Aranow, C., Van Vollenhoven, R., Ramos-Casals, M., Zoma, A., Kalunian, K., Farewell, V., Annals of the Rheumatic Diseases, 2011, 10.1136/ard.2010.138792
  • Surveillance of systemic autoimmune rheumatic diseases using administrative data, Bernatsky, S., Lix, L., Hanly, J.G., Hudson, M., Badley, E., Peschken, C., Pineau, C.A., Clarke, A.E., Fortin, P.R., Smith, M., Bélisle, P., Lagace, C., Bergeron, L., Joseph, L., Rheumatology International, 2011, 10.1007/s00296-010-1591-2
  • Systemic lupus erythematosus disease activity index 2000 responder index-50: A reliable index for measuring improvement in disease activity, Touma, Z., Urowitz, M.B., Fortin, P.R., Landolt, C., Toloza, S.M., Riddell, C., Chandran, V., Eder, L., Ghanem, A., Ziouzina, O., Taghavi-Zadeh, S., Ibañez, D., Gladman, D.D., Journal of Rheumatology, 2011, 10.3899/jrheum.101080
  • Thrombovascular events affect quality of life in patients with systemic lupus erythematosus, Balitsky, A.K., Peeva, V., Su, J., Aghdassi, E., Yeo, E., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Journal of Rheumatology, 2011, 10.3899/jrheum.101054
  • Altered expression of TNF-α signaling pathway proteins in systemic lupus erythematosus, Zhu, L.-J., Landolt-Marticorena, C., Li, T., Yang, X., Yu, X.-Q., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Wither, J.E., Journal of Rheumatology, 2010, 10.3899/jrheum.091123
  • Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus, Urowitz, M.B., Gladman, D., Ibañez, D., Bae, S.C., Sanchez-Guerrero, J., Gordon, C., Clarke, A., Bernatsky, S., Fortin, P.R., Hanly, J.G., Wallace, D.J., Isenberg, D., Rahman, A., Alarcón, G.S., Merrill, J.T., Ginzler, E., Khamashta, M., Nived, O., Sturfelt, G., Bruce, I.N., Steinsson, K., Manzi, S., Ramsey-Goldman, R., Dooley, M.A., Zoma, A., Kalunian, K., Ramos, M., Van Vollenhoven, R.F., Aranow, C., Stoll, T., Petri, M., Maddison, P., Arthritis Care and Research, 2010, 10.1002/acr.20122
  • Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus, Touma, Z., Gladman, D.D., Tulloch-Reid, D., Toloza, S.M., Ibañez, D., Fortin, P.R., Urowitz, M.B., Clinical and Experimental Rheumatology, 2010
  • Clinical and serologic factors associated with lupus pleuritis, Mittoo, S., Gelber, A.C., Hitchon, C.A., Silverman, E.D., Pope, J.E., Fortin, P.R., Pineau, C., Smith, C.D., Arbillaga, H., Gladman, D.D., Urowitz, M.B., Zummer, M., Clarke, A.E., Bernatsky, S., Hudson, M., Tucker, L.B., Petty, R.E., Cooper, G.S., Albert, L., Chedéville, G., Campillo, S., Duffy, K., Scuccimarri, R., Baron, M., Berkson, L., Ramsey, S., Huber, A., Peschken, C.A., Journal of Rheumatology, 2010, 10.3899/jrheum.090249
  • Development and initial validation of a self-assessed lupus organ damage instrument, Costenbader, K.H., Khamashta, M., Ruiz-Garcia, S., Perez-Rodriguez, M.T., Petri, M., Elliott, J., Manzi, S., Karlson, E.W., Turner-Stokes, T., Bermas, B., Coblyn, J., Massarotti, E., Schur, P., Fraser, P., Navarro, I., Hanly, J.G., Shaver, T.S., Katz, R.S., Chakravarty, E., Fortin, P.R., Sanchez, M.L., Liu, J., Michaud, K., Alarcón, G.S., Wolfe, F., Arthritis Care and Research, 2010, 10.1002/acr.20193
  • Occupational and environmental exposures and risk of systemic lupus erythematosus: Silica, sunlight, solvents, Cooper, G.S., Wither, J., Bernatsky, S., Claudio, J.O., Clarke, A., Rioux, J.D., Fortin, P.R., Rheumatology, 2010, 10.1093/rheumatology/keq214
  • Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus, Hanly, J.G., Urowitz, M.B., Su, L., Bae, S.C., Gordon, C., Wallace, D.J., Clarke, A., Bernatsky, S., Isenberg, D., Rahman, A., Alarcón, G.S., Gladman, D.D., Fortin, P.R., Sanchez-Guerrero, J., Romero-Diaz, J., Merrill, J.T., Ginzler, E., Bruce, I.N., Steinsson, K., Khamashta, M., Petri, M., Manzi, S., Dooley, M.A., Ramsey-Goldman, R., Van Vollenhoven, R., Nived, O., Sturfelt, G., Aranow, C., Kalunian, K., Ramos-Casals, M., Zoma, A., Douglas, J., Thompson, K., Farewell, V., Annals of the Rheumatic Diseases, 2010, 10.1136/ard.2008.106351
  • Reply, Fortin, P.R., Jung, H., Lou, W., Arthritis and Rheumatism, 2010, 10.1002/art.27620
  • Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus, Yip, J., Aghdassi, E., Su, J., Lou, W., Reich, H., Bargman, J., Scholey, J., Gladman, D.D., Urowitz, M.B., Fortin, P.R., Journal of Rheumatology, 2010, 10.3899/jrheum.091028
  • The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus, Jung, H., Bobba, R., Su, J., Shariati-Sarabi, Z., Gladman, D.D., Urowitz, M., Lou, W., Fortin, P.R., Arthritis and Rheumatism, 2010, 10.1002/art.27289
  • The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus, Aghdassi, E., Morrison, S., Landolt-Marticorena, C., Su, J., Pineau, C.A., Gladman, D., Urowitz, M., Pope, J., Peschken, C., DaCosta, D., Wither, J., Fortin, P.R., Journal of Rheumatology, 2010, 10.3899/jrheum.090761
  • Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort, Neville, C., Rauch, J., Kassis, J., Solymoss, S., Joseph, L., Belisle, P., Levine, J.S., Fortin, P.R., Thrombosis and Haemostasis, 2009, 10.1160/TH08-06-0384
  • Barriers to healthcare in a multiethnic cohort of systemic lupus erythematosus (SLE) patients: Patient and physician perceptions, Law, G., Pope, J., Lalani, S., Silverman, E., Cooper, G., Fortin, P., Zummer, M., Smith, C.D., Petty, R., Tucker, L., Albert, L., Huber, A., Ramsey, S., Arbillaga, H., Chedéville, G., Hudson, M., Peschken, C., Clinical Medicine: Arthritis and Musculoskeletal Disorders, 2009, 10.4137/cmamd.s2136
  • Common variants in the NLRP3 region contribute to Crohn's disease susceptibility, Villani, A.-C., Lemire, M., Fortin, G., Louis, E., Silverberg, M.S., Collette, C., Baba, N., Libioulle, C., Belaiche, J., Bitton, A., Gaudet, D., Cohen, A., Langelier, D., Fortin, P.R., Wither, J.E., Sarfati, M., Rutgeerts, P., Rioux, J.D., Vermeire, S., Hudson, T.J., Franchimont, D., Nature Genetics, 2009, 10.1038/ng.285
  • Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus, Landolt-Marticorena, C., Bonventi, G., Lubovich, A., Ferguson, C., Unnithan, T., Su, J., Gladman, D.D., Urowitz, M., Fortin, P.R., Wither, J., Annals of the Rheumatic Diseases, 2009, 10.1136/ard.2008.093146
  • Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus, Liang, M.H., Simard, J.F., Costenbader, K., Dore, B.T., Ward, M., Fortin, P.R., Illei, G.G., Manzi, S., Mittleman, B., Buyon, J., Gupta, S., Abrahamowicz, M., Endocrine, Metabolic and Immune Disorders - Drug Targets, 2009, 10.2174/187153009787582388
  • The 1000 Canadian faces of lupus: Determinants of disease outcome in a large multiethnic cohort, Peschken, C.A., Katz, S.J., Silverman, E., Pope, J.E., Fortin, P.R., Pineau, C., Smith, C.D., Arbillaga, H.O., Gladman, D.D., Urowitz, M., Zummer, M., Clarke, A., Bernatsky, S., Hudson, M., Cooper, G.S., Albert, L., Carette, S., Inman, R.D., Hitchon, C., Tucker, L., Petty, R., Chedéville, G., Campillo, S., Duffy, K., Scuccimarri, R., Baron, M., Berkson, L., Ramsey, S., Huber, A., Journal of Rheumatology, 2009, 10.3899/jrheum.080912
  • Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: Data from North and South America, Spain and Portugal, Pons-Estel, B.A., Sánchez-Guerrero, J., Romero-Díaz, J., Iglesias-Gamarra, A., Bonfa, E., Borba, E.F., Shinjo, S.K., Bernatsky, S., Clarke, A., García, M.A., Marcos, J.C., Duarte, A., Berbotto, G.A., Scherbarth, H., Marques, C.D., Onetti, L., Saurit, V., Souza, A.W.S., Velozo, E., Catoggio, L.J., Neira, O., Burgos, P.I., Ramirez, L.A., Molina, J.F., De La Torre, I.G., Silvariño, R., Manni, J.A., Durán-Barragán, S., Vilá, L.M., Fortin, P.R., Calvo-Alén, J., Santos, M.J., Portela, M., Esteva-Spinetti, M.H., Weisman, M., Acevedo, E.M., Segami, M.I., Gentiletti, S.B., Roldán, J., Navarro, I., Gonzalez, E., Liu, J.M., Karlson, E.W., Costenbader, K.H., Wolfe, F., Alarcón, G.S., Lupus, 2009, 10.1177/0961203309105590
  • Work disability in systemic lupus erythematosus, Dhanhani, A.M.A.L., Gignac, M.A.M., Jiandong, S.U., Fortin, P.R., Arthritis Care and Research, 2009, 10.1002/art.24347
  • Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial, Cardiel, M.H., Tumlin, J.A., Furie, R.A., Wallace, D.J., Joh, T., Linnik, M.D., Abeles, M., Aelion, J., Appel, G.B., Aranow, C., Ballou, S., Becker, M.A., Belmont, H.M., Boling, E.P., Bombardieri, S., Brodeur, J., Buyon, J., Condemi, J.J., Cronin, M.E., Cush, J.J., DeHoratius, R., Desir, D., Donohue, J., Edwards, M., El-Shahawy, M.A., Emery, P., Ensworth, S., Espinoza, L.R., Fondal, M., Fortin, P., Geppert, T., Gilkeson, G.S., Ginzler, E., Gorevic, P., Granda, J., Grossman, J., Hiepe, F., Howard, P., Hura, C.E., Jaffer, A., Jakes, J., Kalden, J.R., Kammer, G.M., Kaplan, M.J., Kaplan, S., Katz, R., Kennedy, A., Kenney, H.M., Khamashta, M., Kivitz, A.J., Kovacs, C., Krishnan, M., Kurtzman, N.A., Liebling, M., Lourie, S.H., Loveless, J., Manion, C.V., Manzi, S., Martin, K., McKay, J., Mease, P.J., Merrill, J.T., Moreland, L.W., Moritz, C., Neuwelt, C.M., Petri, M., Pogue, B.C., Quinet, R.J., Ramsey-Goldman, R., Roth, A., Rothfield, N., Scarpa, N., Schneider, M., Shergy, W.J., Sherrer, Y., Sibilia, J., Sisay, M., Smith, D., Spinowitz, B., Spira, M., Stevens, M.P., Sturfelt, G., Surbeck, W., Tindall, E.A., Torres, A., Van Vollenhoven, R., Vijayan, A., Vilardell-Tarres, M., Weaver, C., Williams, G.W., Zummer, M., Arthritis and Rheumatism, 2008, 10.1002/art.23673
  • Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort, Urowitz, M.B., Gladman, D., Ibañez, D., Fortin, P., Sanchez-Guerrero, J., Bae, S., Clarke, A., Bernatsky, S., Gordon, C., Hanly, J., Wallace, D., Isenberg, D., Ginzler, E., Merrill, J., Alarcón, G.S., Steinsson, K., Petri, M., Dooley, M.A., Bruce, I., Manzi, S., Khamashta, M., Ramsey-Goldman, R., Zoma, A., Sturfelt, G., Nived, O., Maddison, P., Font, J., Van Vollenhoven, R., Aranow, C., Kalunian, K., Stoll, T., Arthritis Care and Research, 2008, 10.1002/art.23353
  • Association of LY9 in UK and Canadian SLE families, Graham, D.S.C., Vyse, T.J., Fortin, P.R., Montpetit, A., Cai, Y.-C., Lim, S., McKenzie, T., Farwell, L., Rhodes, B., Chad, L., Hudson, T.J., Sharpe, A., Terhorst, C., Greenwood, C.M.T., Wither, J., Rioux, J.D., Genes and Immunity, 2008, 10.1038/sj.gene.6364453
  • Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international inception cohort study, Hanly, J.G., Urowitz, M.B., Siannis, F., Farewell, V., Gordon, C., Bae, S.C., Isenberg, D., Dooley, M.A., Clarke, A., Bernatsky, S., Gladman, D., Fortin, P.R., Manzi, S., Steinsson, K., Bruce, I.N., Ginzler, E., Aranow, C., Wallace, D.J., Ramsey-Goldman, R., Van Vollenhoven, R., Sturfelt, G., Nived, O., Sanchez-Guerrero, J., Alarcón, G.S., Petri, M., Khamashta, M., Zoma, A., Font, J., Kalunian, K., Douglas, J., Qi, Q., Thompson, K., Merrill, J.T., Arthritis and Rheumatism, 2008, 10.1002/art.23218
  • Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus, Chang, N.-H., McKenzie, T., Bonventi, G., Landolt-Marticorena, C., Fortin, P.R., Gladman, D., Urowitz, M., Wither, J.E., Journal of Immunology, 2008, 10.4049/jimmunol.180.2.1276
  • Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus, Graham, R.R., Cotsapas, C., Davies, L., Hackett, R., Lessard, C.J., Leon, J.M., Burtt, N.P., Guiducci, C., Parkin, M., Gates, C., Plenge, R.M., Behrens, T.W., Wither, J.E., Rioux, J.D., Fortin, P.R., Cunninghame Graham, D., Wong, A.K., Vyse, T.J., Daly, M.J., Altshuler, D., Moser, K.L., Gaffney, P.M., Nature Genetics, 2008, 10.1038/ng.200
  • Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease, Hudson, M., Bernatsky, S., Taillefer, S., Fortin, P.R., Wither, J., Baron, M., Journal of Clinical Epidemiology, 2008, 10.1016/j.jclinepi.2007.08.010
  • Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?, Karp, I., Abrahamowicz, M., Fortin, P.R., Pilote, L., Neville, C., Pineau, C.A., Esdaile, J.M., Arthritis Care and Research, 2008, 10.1002/art.23352
  • Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity, Wither, J., Cai, Y.-C., Lim, S., McKenzie, T., Roslin, N., Claudio, J.O., Cooper, G.S., Hudson, T.J., Paterson, A.D., Greenwood, C.M.T., Gladman, D., Pope, J., Pineau, C.A., Smith, C.D., Hanly, J.G., Peschken, C., Boire, G., Urowitz, M., Bernatsky, S., Clarke, A., Rich., E., Hitchon, C., Carette, S., Inman, R., Albert, L., Barr, S., Fortin, P.R., Arthritis Research and Therapy, 2008, 10.1186/ar2505
  • Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study, Hanly, J.G., Urowitz, M.B., Su, L., Sanchez-Guerrero, J., Bae, S.C., Gordon, C., Wallace, D.J., Isenberg, D., Alarcón, G.S., Merrill, J.T., Clarke, A., Bernatsky, S., Dooley, M.A., Fortin, P.R., Gladman, D., Steinsson, K., Petri, M., Bruce, I.N., Manzi, S., Khamashta, M., Zoma, A., Font, J., Van Vollenhoven, R., Aranow, C., Ginzler, E., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Kalunian, K., Douglas, J., Qiufen Qi, K., Thompson, K., Farewell, V., Arthritis Care and Research, 2008, 10.1002/art.23566
  • Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial, Fortin, P.R., Abrahamowicz, M., Ferland, D., Lacaille, D., Smith, C.D., Zummer, M., Arthritis Care and Research, 2008, 10.1002/art.24068
  • The prevalence and accuracy of self-reported history of 11 autoimmune diseases, Cooper, G.S., Wither, J., Mckenzie, T., Claudio, J.O., Bernatsky, S., Fortin, P.R., Hudson, T., Greenwood, C.M.T., Pope, J., Gladman, D., Urowitz, M., Hanly, J., Smith, C.D., Clarke, A., Peschken, C., Hitchon, C., Zummer, M., Barr, S., Boire, G., Rich, E., Senecal, J.-L., Carette, S., Inman, R., Journal of Rheumatology, 2008
  • The relationship between cancer and medication exposures in systemic lupus erythaematosus: A case-cohort study, Bernatsky, S., Joseph, L., Boivin, J.-F., Gordon, C., Urowitz, M., Gladman, D., Fortin, P.R., Ginzler, E., Bae, S.-C., Barr, S., Edworthy, S., Isenberg, D., Rahman, A., Petri, M., Alarcón, G.S., Aranow, C., Dooley, M.-A., Rajan, R., Sénécal, J.-L., Zummer, M., Manzi, S., Ramsey-Goldman, R., Clarke, A.E., Annals of the Rheumatic Diseases, 2008, 10.1136/ard.2006.069039
  • Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: Data from an international inception cohort, Urowitz, M.B., Gladman, D., Ibañez, D., Fortin, P., Sanchez-Guerrero, J., Bae, S., Clarke, A., Bernatsky, S., Gordon, C., Hanly, J., Wallace, D., Isenberg, D., Ginzler, E., Merrill, J., Alarcon, G., Steinsson, K., Petri, M., Dooley, M.A., Bruce, I., Manzi, S., Khamashta, M., Ramsey-Goldman, R., Zoma, A., Sturfelt, G., Nived, O., Maddison, P., Font, J., Van Vollenhoven, R., Aranow, C., Kalunian, K., Stoll, T., Buyon, J., Lupus, 2007, 10.1177/0961203307081113
  • Costs of rheumatoid arthritis: New estimates from the human capital method and comparison to the willingness-to-pay method, Fautrel, B., Clarke, A.E., Guillemin, F., Adam, V., St-Pierre, Y., Panaritis, T., Fortin, P.R., Menard, H.A., Donaldson, C., Penrod, J.R., Medical Decision Making, 2007, 10.1177/0272989X06297389
  • Lung cancer in systemic lupus erythematosus, Bin, J., Bernatsky, S., Gordon, C., Boivin, J.-F., Ginzler, E., Gladman, D., Fortin, P.R., Urowitz, M., Manzi, S., Isenberg, D., Rahman, A., Petri, M., Nived, O., Sturfeldt, G., Ramsey-Goldman, R., Clarke, A.E., Lung Cancer, 2007, 10.1016/j.lungcan.2007.01.007
  • Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study, Hanly, J.G., Urowitz, M.B., Sanchez-Guerrero, J., Bae, S.C., Gordon, C., Wallace, D.J., Isenberg, D., Alarcón, G.S., Clarke, A., Bernatsky, S., Merrill, J.T., Petri, M., Dooley, M.A., Gladman, D., Fortin, P.R., Steinsson, K., Bruce, I., Manzi, S., Khamashta, M., Zoma, A., Aranow, C., Ginzler, E., Van Vollenhoven, R., Font, J., Sturfelt, G., Nived, O., Ramsey-Goldman, R., Kalunian, K., Douglas, J., Thompson, K., Farewell, V., Arthritis and Rheumatism, 2007, 10.1002/art.22305
  • The Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: A National Multidisciplinary Stakeholder Project, Maksymowych, W.P., Gladman, D., Rahman, P., Boonen, A., Bykerk, V., Choquette, D., Dimond, S., Fortin, P., Karsh, J., Klinkhoff, A.V., Mosher, D., Mulholland, K., Olszynski, W.P., Russell, A.S., Savage, L., Shanner, L., Shojania, K., Starr, M., Thomson, G., Zummer, M., Inman, R., Journal of Rheumatology, 2007
  • The systemic lupus erythematosus tri-nation study: Cumulative indirect costs, Panopalis, P., Petri, M., Manzi, S., Isenberg, D.A., Gordon, C., Senégal, J.-L., Penrod, J.R., Joseph, L., St. Pierre, Y., Pineau, C., Fortin, P.R., Sutcliffe, N., Goulet, J.-R., Choquette, D., Grodzicky, T., Esdaile, J.M., Clarke, A.E., Arthritis Care and Research, 2007, 10.1002/art.22470
  • "What do you expect? You're just getting older": A comparison of perceived osteoarthritis-related and aging-related health experiences in middle- and older-age adults, Gignac, M.A.M., Davis, A.M., Hawker, G., Wright, J.G., Mahomed, N., Fortin, P.R., Badley, E.M., Arthritis Care and Research, 2006, 10.1002/art.22338
  • Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus, Tisseverasinghe, A., Lim, S., Greenwood, C., Urowitz, M., Gladman, D., Fortin, P.R., Arthritis and Rheumatism, 2006, 10.1002/art.21929
  • Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus, Chagnon, P., Schneider, R., Hébert, J., Fortin, P.R., Provost, S., Belisle, C., Gingras, M., Bolduc, V., Perreault, C., Silverman, E., Busque, L., Arthritis and Rheumatism, 2006, 10.1002/art.21733
  • Malignancy prevalence in the first-degree relatives of persons with systemic lupus erythematous: A pilot study [1], Bernatsky, S., Clarke, A., Pope, J., Hanly, J.G., Smith, C.D., Peschken, C., Rich, E., Boire, G., Fortin, P.R., Lupus, 2006, 10.1177/0961203306072424
  • Mortality in systemic lupus erythematosus, Bernatsky, S., Boivin, J.-F., Joseph, L., Manzi, S., Ginzler, E., Gladman, D.D., Urowitz, M., Fortin, P.R., Petri, M., Barr, S., Gordon, C., Bae, S.-C., Isenberg, D., Zoma, A., Aranow, C., Dooley, M.-A., Nived, O., Sturfelt, G., Steinsson, K., Alarcón, G., Senécal, J.-L., Zummer, M., Hanly, J., Ensworth, S., Pope, J., Edworthy, S., Rahman, A., Sibley, J., El-Gabalawy, H., McCarthy, T., St. Pierre, Y., Clarke, A., Ramsey-Goldman, R., Arthritis and Rheumatism, 2006, 10.1002/art.21955
  • Mortality related to cerebrovascular disease in systemic lupus erythematosus, Bernatsky, S., Clarke, A., Gladman, D.D., Urowitz, M., Fortin, P.R., Barr, S.G., Senécal, J.-L., Zummer, M., Edworthy, S., Sibley, J., Pope, J., Ensworth, S., Ramsey-Goldman, R., Hanly, J.G., Lupus, 2006, 10.1177/0961203306073133
  • Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus, Chang, E.R., Pineau, C.A., Bernatsky, S., Neville, C., Clarke, A.E., Fortin, P.R., Journal of Rheumatology, 2006
  • The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials, Liang, M.H., Schur, P.H., Fortin, P., St.Clair, E.W., Balow, J.E., Costenbader, K., Crofford, L., De Pablo, P., Dooley, M.A., Finckh, A., Gordon, C.P., Lundberg, I.E., Meyrier, A., Nived, O., Ponticelli, C., Schneider, M.K., Singh, A., Wallace, D.J., Arthritis and Rheumatism, 2006, 10.1002/art.21625
  • The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies, Neville, C., Rauch, J., Kassis, J., Solymoss, S., Joseph, L., Belisle, P., Subang, R., Chang, E.R., Fortin, P.R., Rheumatology, 2006, 10.1093/rheumatology/kel050
  • An international cohort study of cancer in systemic lupus erythematosus, Bernatsky, S., Boivin, J.F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P.R., Petri, M., Edworthy, S., Barr, S., Gordon, C., Bae, S.C., Sibley, J., Isenberg, D., Rahman, A., Aranow, C., Dooley, M.A., Steinsson, K., Nived, O., Sturfelt, G., Alarcón, G., Senécal, J.L., Zummer, M., Hanly, J., Ensworth, S., Pope, J., El-Gabalawy, H., McCarthy, T., St. Pierre, Y., Ramsey-Goldman, R., Clarke, A., Arthritis and Rheumatism, 2005, 10.1002/art.21029
  • Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?, Marra, C.A., Rashidi, A.A., Guh, D., Kopec, J.A., Abrahamowicz, M., Esdaile, J.M., Brazier, J.E., Fortin, P.R., Anis, A.H., Quality of Life Research, 2005, 10.1007/s11136-004-6012-0
  • Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus, Sarabi, Z.S., Chang, E., Bobba, R., Ibanez, D., Gladman, D., Urowitz, M., Fortin, P.R., Arthritis Care and Research, 2005, 10.1002/art.21314
  • Non-Hodgkin's lymphoma in systemic lupus erythematosus, Bernatsky, S., Ramsey-Goldman, R., Rajan, R., Boivin, J.-F., Joseph, L., Lachance, S., Cournoyer, D., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P.R., Edworthy, S., Barr, S., Gordon, C., Bae, S.-C., Sibley, J., Steinsson, K., Nived, O., Sturfelt, G., St. Pierre, Y., Clarke, A., Annals of the Rheumatic Diseases, 2005, 10.1136/ard.2004.034504
  • Race/ethnicity and cancer occurrence in systemic lupus erythematosus, Bernatsky, S., Boivin, J.F., Joseph, L., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P., Gordon, C., Barr, S., Edworthy, S., Bae, S.C., Petri, M., Sibley, J., Isenberg, D., Rahman, A., Steinsson, K., Aranow, C., Dooley, M.A., Alarcon, G.S., Hanly, J., Sturfelt, G., Nived, O., Pope, J., Ensworth, S., Rajan, R., El-Gabalawy, H., McCarthy, T., St. Pierre, Y., Clarke, A., Ramsey-Goldman, R., Arthritis Care and Research, 2005, 10.1002/art.21458
  • Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus, Linnik, M.D., Hu, J.Z., Heilbrunn, K.R., Strand, V., Hurley, F.L., Joh, T., Alarcón-Segovia, D., Appel, G., Aranow, C., Ballou, S., Becker, M.A., Becker, N., Belmont, M.H., Bohan, A., Boling, E.P., Bombardieri, S., Brelsford, W.G., Buyon, J.P., Cardiel, M.H., Carteron, N.L., Condemi, J.J., Cronin, M.E., Cush, J.J., DeHoratius, R., Desir, D., Edwards, M., El-Shahawy, M.A., Emery, P., Espinoza, L.R., Finkel, T.H., Fondal, M., Fortin, P., Furie, R.A., Genovese, M.C., Geppert, T., Gil-Aguado, A., Gilkeson, G.S., Ginzler, E., Gluck, O.S., Granda, J.L., Grossman, J., Hiepe, F., Hill, M., Howard, P., Hura, C., Ingelmo, M., Jaffer, A., Jakes, J., Kalden, J.P., Kalunian, K.C., Kammer, G.M., Kanick, K., Kaplan, J., Kaplan, S., Katz, R., Kenney, H.M., Khamashta, M., Kivitz, A.J., Krishnan, M., Kurtzman, N.A., Liebling, M., Lindberg, J.S., Lourie, S.H., Loveless, J., Manzi, S., Martin, K., McKay, J., Merrill, J., Moreland, L.W., Neuwelt, M.C., Petri, M., Poque, B.C., Quinet, R.J., Ramsey-Goldman, R., Rosenblatt, S.G., Rothfield, N., Scarpa, N., Schneider, M., Schousboe, J.T., Sewell, L.K., Shergy, W.J., Sherrer, Y., Sibilia, J., Smith, D., Spinowitz, B., Spira, M., Staud, R., Stern, S., Stevens, M.P., Sturfelt, G., Surbeck, W., Tindall, E.A., Torres, A., Tumlin, J., Van Vollenhoven, R., Varga, J., Vijayan, A., Vilardell-Tarres, M., Wallace, D., Weaver, C., Zummer, M., Arthritis and Rheumatism, 2005, 10.1002/art.20980
  • Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer, Benk, V., Al-Herz, A., Gladman, D., Urowitz, M., Fortin, P.R., Arthritis Care and Research, 2005, 10.1002/art.20912
  • The systemic lupus erythematosus tri-nation study: Longitudinal changes in physical and mental well-being, Panopalis, P., Petri, M., Manzi, S., Isenberg, D.A., Gordon, C., Senecal, J.-L., Penrod, J.R., Joseph, L., St. Pierre, Y., Pineau, C., Fortin, P.R., Sutcliffe, N., Goulet, J.-R., Choquette, D., Grodzicky, T., Esdaile, J.M., Clarke, A.E., Panaritis, T., Panaritis, P., Margonis, K., Trifero, M., Ferland, D., Neville, C., Orsini-Dudin, M., Rairie, J., Heaton, S., Rheumatology, 2005, 10.1093/rheumatology/keh580
  • Thrombosis and inflammation: A question in need of an answer, Bobba, R., Landolt-Marticorena, C., Fortin, P.R., Journal of Rheumatology, 2005
  • Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: The patient perspective, Fautrel, B., Clarke, A.E., Guillemin, F., Adam, V., St-Pierre, Y., Panaritis, T., Fortin, P.R., Menard, H.A., Donaldson, C., Penrod, J.R., Journal of Rheumatology, 2005
  • Antiphospholipid antibodies and thrombosis: Association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis, Kassis, J., Neville, C., Rauch, J., Busque, L., Chang, E.R., Joseph, L., Le Comte, M., Subang, R., Fortin, P.R., Thrombosis and Haemostasis, 2004, 10.1160/TH04-03-0138
  • Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: Report of a consensus meeting, Liang, M.H., Fortin, P., Schneider, M., Abrahamowicz, M., Alarcón, G.S., Balow, J., Benito-Garcia, E., Bischoff-Ferrari, H., Bombardieri, S., Buyon, J., Chehab, G., Crofford, L., De Pablo, P., Esdaile, J.M., Fischer-Betz, R., Gladman, D., Illei, G., Johnson, K., Kalden, J., Khamashta, M., Koike, T., Lockshin, M., Manzi, S., McCune, J., Meyrier, A., Mikdashi, J., Moore, A., Mosca, M., Petri, M., Phillips, C., Roberts Jr., N., Schur, P., Smolen, J., St.Clair, E.W., Strand, V., Arthritis and Rheumatism, 2004, 10.1002/art.20599
  • Effect of delay in initiating radiotherapy for patients with early stage breast cancer, Benk, V., Joseph, L., Fortin, P., Zhang, G., Belisle, P., Levinton, C., Ho, V., Freeman, C.R., Clinical Oncology, 2004, 10.1016/j.clon.2003.10.008
  • Osteoporosis in systemic lupus erythematosus: Factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density, Pineau, C.A., Urowitz, M.B., Fortin, P.J., Ibanez, D., Gladman, D.D., Lupus, 2004, 10.1191/0961203303lu1036oa
  • The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity, Liang, M.H., Fortin, P., Schneider, M., Abrahamowicz, M., Alarcón, G.S., Bombardieri, S., Balow, J., Benito-Garcia, E., Bischoff-Ferrari, H., Buyon, J., Chehab, G., Costenbader, K., Crofford, L., De Pablo, P., Esdaile, J.M., Finckh, A., Fischer-Betz, R., Gladman, D., Gordon, C., Illei, G., Isenberg, D., Iking-Konert, C., Johnson, K., Kalden, J., Khamashta, M., Koike, T., Lockshin, M., Manzi, S., McCune, J., Meyrier, A., Mikdashi, J., Moore, A., Mosca, M., Petri, M., Phillips, C., Roberts Jr., N., Schur, P., Smolen, J., St.Clair, E.W., Strand, V., Arthritis and Rheumatism, 2004, 10.1002/art.20628
  • The systemic lupus erythematosus tri-nation study: Absence of a link between health resource use and health outcome, Clarke, A.E., Petri, M., Manzi, S., Isenberg, D.A., Gordon, C., Senécal, J.-L., Penrod, J., Joseph, L., St Pierre, Y., Fortin, P.R., Sutcliffe, N., Goulet, J.R., Choquette, D., Grodzicky, T., Esdaile, J.M., Panaritis, T., Panaritis, P., Margonis, K., Trifero, M., Ferland, D., Neville, C., Orsini-Dudin, M., Rairie, J., Heaton, S., Rheumatology, 2004, 10.1093/rheumatology/keh229
  • A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome, Crowther, M.A., Ginsberg, J.S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M., Kovacs, M.J., New England Journal of Medicine, 2003, 10.1056/NEJMoa035241
  • Determinants of discordance between patients and physicians in their assessment of lupus disease activity, Yen, J.C., Abrahamowicz, M., Dobkin, P.L., Clarke, A.E., Battista, R.N., Fortin, P.R., Journal of Rheumatology, 2003
  • Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus, Edworthy, S.M., Dobkin, P.L., Clarke, A.E., Da Costa, D., Dritsa, M., Fortin, P.R., Barr, S., Ensworth, S., Esdaile, J.M., Beaulieu, A., Zummer, M., Senécal, J.-L., Goulet, J.-R., Choquette, D., Rich, E., Smith, D., Cividino, A., Gladman, D., Devins, G.M., Journal of Rheumatology, 2003
  • Intravenous cyclophosphamide and high dose corticosteroids improve MRI lesions in demyelinating syndrome in systemic lupus erythematosus, Leung, F.K., Fortin, P.R., Journal of Rheumatology, 2003
  • Patient expectations and total joint arthroplasty [1] (multiple letters), Woolhead, G., Donovan, J., Dieppe, P., Mahomed, N.N., Liang, M.H., Daltroy, L.H., Fortin, P.R., Katz, J.N., Journal of Rheumatology, 2003
  • Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity, Stone, M., Fortin, P.R., Pacheco-Tena, C., Inman, R.D., Journal of Rheumatology, 2003
  • The Presence of Multiple Prothrombotic Risk Factors Is Associated with a Higher Risk of Thrombosis in Individuals with Anticardiolipin Antibodies, Hudson, M., Herr, A.-L., Rauch, J., Neville, C., Chang, E., Ibrahim, R., Séguin, C., Kassis, J., Busque, L., Fortin, P.R., Journal of Rheumatology, 2003
  • Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies, Neville, C., Rauch, J., Kassis, J., Chang, E.R., Joseph, L., Le Comte, M., Fortin, P.R., Thrombosis and Haemostasis, 2003, 10.1055/s-0037-1613606
  • Validation of a systemic lupus activity questionnaire (SLAQ) for population studies, Karlson, E.W., Daltroy, L.H., Rivest, C., Ramsey-Goldman, R., Wright, E.A., Partridge, A.J., Liang, M.H., Fortin, P.R., Lupus, 2003, 10.1191/0961203303lu332oa
  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis, Hoffman, G.S., Cid, M.C., Hellmann, D.B., Guillevin, L., Stone, J.H., Schousboe, J., Cohen, P., Calabrese, L.H., Dickler, H., Merkel, P.A., Fortin, P., Flynn, J.A., Locker, G.A., Easley, K.A., Schned, E., Hunder, G.G., Sneller, M.C., Tuggle, C., Swanson, H., Hernández-Rodríguez, J., Lopez-Soto, A., Bork, D., Hoffman, D.B., Kalunian, K., Klashman, D., Wilke, W.S., Scheetz, R.J., Mandell, B.F., Fessler, B.J., Kosmorsky, G., Prayson, R., Luqmani, R.A., Nuki, G., McRorie, E., Sherrer, Y., Baca, S., Walsh, B., Ferland, D., Soubrier, M., Choi, H.K., Gross, W., Segal, A.M., Ludivico, C., Puechal, X., Arthritis and Rheumatism, 2002, 10.1002/art.10262
  • Association of autoantibodies to nuclear lamin B1 with thromboprotection in systemic lupus erythematosus: Lack of evidence for a direct role of lamin B1 in apoptotic blebs, Dieudé, M., Senécal, J.-L., Rauch, J., Hanly, J.G., Fortin, P., Brassard, N., Raymond, Y., Arthritis and Rheumatism, 2002, 10.1002/art.10552
  • Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians, Chang, E., Abrahamowicz, M., Ferland, D., Fortin, P.R., Journal of Clinical Epidemiology, 2002, 10.1016/S0895-4356(01)00509-1
  • Counterbalancing patient demands with evidence: Results from a Pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus, Dobkin, P.L., Da Costa, D., Joseph, L., Fortin, P.R., Edworthy, S., Barr, S., Ensworth, S., Esdaile, J.M., Beaulieu, A., Zummer, M., Senécal, J.-L., Goulet, J.-R., Choquette, D., Rich, E., Smith, D., Cividino, A., Gladman, D., St-Pierre, Y., Clarke, A.E., Annals of Behavioral Medicine, 2002, 10.1207/S15324796ABM2402_05
  • Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies, Chopra, N., Koren, S., Greer, W.L., Fortin, P.R., Rauch, J., Fortin, I., Senécal, J.-L., Docherty, P., Hanly, J.G., Journal of Rheumatology, 2002
  • Measuring clinically important changes with patient-oriented questionnaires., Liang, M.H., Lew, R.A., Stucki, G., Fortin, P.R., Daltroy, L., Medical care, 2002, 10.1097/00005650-200204001-00008
  • Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity, Chang, E.R., Abrahamowicz, M., Ferland, D., Fortin, P.R., Journal of Rheumatology, 2002
  • Purpura fulminans and anticardiolipin antibodies in a patient with Grave's disease, Ligier, S., Pham, C.D., Watters, A.K., Kassis, J., Fortin, P.R., Scandinavian Journal of Rheumatology, 2002, 10.1080/030097402320817112
  • The importance of patient expectations in predicting functional outcomes after total joint arthroplasty, Mahomed, N.N., Liang, M.H., Cook, E.F., Daltroy, L.H., Fortin, P.R., Fossel, A.H., Katz, J.N., Journal of Rheumatology, 2002
  • The rate and pattern of organ damage in late onset systemic lupus erythematosus, Maddison, P., Farewell, V., Isenberg, D., Aranow, C., Bae, S.-C., Barr, S., Buyon, J., Fortin, P., Ginzler, E., Gladman, D., Hanly, J., Manzi, S., Nived, O., Petri, M., Ramsey-Goldman, R., Sturfelt, G., Journal of Rheumatology, 2002
  • Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee, Fortin, P.R., Penrod, J.R., Clarke, A.E., St-Pierre, Y., Joseph, L., Bélisle, P., Liang, M.H., Ferland, D., Phillips, C.B., Mahomed, N., Tanzer, M., Sledge, C., Fossel, A.H., Katz, J.N., Arthritis and Rheumatism, 2002, 10.1002/art.10631
  • Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada, Neville, C., Whalley, D., McKenna, S., Le Comte, M., Fortin, P.R., Journal of Rheumatology, 2001
  • Living with lupus: A prospective Pan-Canadian study, Dobkin, P.L., Da Costa, D., Fortin, P.R., Edworthy, E., Barr, S., Esdaile, J.M., Senécal, J.-L., Goulet, J.-R., Choquette, D., Rich, E., Beaulieu, A., Cividino, A., Ensworth, S., Smith, D., Zummer, M., Gladman, D., Clarke, A.E., Journal of Rheumatology, 2001
  • The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus, Wang, C., Mayo, N.E., Fortin, P.R., Journal of Rheumatology, 2001
  • Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus, Esdaile, J.M., Abrahamowicz, M., Grodzicky, T., Li, Y., Panaritis, C., Berger, R.D., Cé, R., Grover, S.A., Fortin, P.R., Clarke, A.E., Senécal, J.-L., Arthritis and Rheumatism, 2001, 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I
  • A subset of rheumatoid factors crossreacts with cardiolipin in patients positive for IgM rheumatoid factor and anticardiolipin antibodies [4], Galperin, I., Fortin, P.R., Subang, R., Newkirk, M.M., Rauch, J., Journal of Rheumatology, 2000
  • Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis, Lucey, M.D., Newkirk, M.M., Neville, C., Lepage, K., Fortin, P.R., Journal of Rheumatology, 2000
  • Determinants of health status in fibromyalgia: A comparative study with systemic lupus erythematosus, Da Costa, D., Dobkin, P.L., Fitzcharles, M.-A., Fortin, P.R., Beaulieu, A., Zummer, M., Senécal, J.-L., Goulet, J.R., Rich, E., Choquette, D., Clarke, A.E., Journal of Rheumatology, 2000
  • Do lupus disease activity measures detect clinically important change?, Fortin, P.R., Abrahamowicz, M., Clarke, A.E., Neville, C., Du Berger, R., Fraenkel, L., Liang, M.H., Journal of Rheumatology, 2000
  • Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity, Neville, C., Clarke, A.E., Joseph, L., Belisle, P., Ferland, D., Fortin, P.R., Journal of Rheumatology, 2000
  • The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for systemic lupus erythematosus international comparison, Gladman, D.D., Goldsmith, C.H., Urowitz, M.B., Bacon, P., Fortin, P., Ginzler, E., Gordon, C., Hanly, J.G., Isenberg, D.A., Petri, M., Nived, O., Snaith, M., Sturfelt, G., Journal of Rheumatology, 2000
  • The use of alternative medical therapies in patients with systemic lupus erythematosus, Moore, A.D., Petri, M.A., Manzi, S., Isenberg, D.A., Gordon, C., Senécal, J.-L., Pierre, Y.S.T., Joseph, L., Penrod, J., Fortin, P.R., Sutcliffe, N., Goulet, J.R., Choquette, D., Grodzicky, T., Esdaile, J.M., Clarke, A.E., Arthritis and Rheumatism, 2000, 10.1002/1529-0131(200006)43:6<1410::AID-ANR27>3.0.CO;2-U
  • Underestimating the value of women: Assessing the indirect costs of women with systemic lupus erythematosus, Clarke, A.E., Penrod, J., St. Pierre, Y., Petri, M.A., Manzi, S., Isenberg, D.A., Gordon, C., Senecal, J.-L., Fortin, P.R., Sutcliffe, N., Goulet, J.R., Choquette, D., Grodzicky, T., Esdaile, J.M., Journal of Rheumatology, 2000
  • Vasculitis and malignancy, Fortin, P.R., Inflammatory Diseases of Blood Vessels, 2000, 10.1201/b14012
  • A conceptual framework for clinical trials in SLE and other multisystem diseases, Liang, M.H., Corzillius, M., Bae, S.-C., Fortin, P., Esdaile, J.M., Abrahamowicz, M., Lupus, 1999, 10.1191/096120399680411290
  • An international perspective on the well being and health care costs for patients with systemic lupus erythematosus, Clarke, A.E., Petri, M.A., Manzi, S., Isenberg, D.A., Gordon, C., Senecal, J.-L., St. Pierre, Y., Joseph, L., Penrod, J., Fortin, P.R., Sutcliffe, N., Goulet, J.R., Choquette, D., Grodzicky, T., Danoff, D.S., Ho, V., Esdaile, J.M., Journal of Rheumatology, 1999
  • Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices, Moore, A.D., Clarke, A.E., Danoff, D.S., Joseph, L., Bélisle, P., Neville, C., Fortin, P.R., Journal of Rheumatology, 1999
  • Discontinuation of antimalarial drugs in systemic lupus erythematosus, Wang, C., Fortin, P.R., Li, Y., Panaritis, T., Gans, M., Esdaile, J.M., Journal of Rheumatology, 1999
  • Discordance between patients and their physicians in the assessment of lupus disease activity: Relevance for clinical trials, Yen, J.C., Neville, C., Fortin, P.R., Lupus, 1999, 10.1191/096120399680411362
  • Outcomes of total hip and knee replacement: Preoperative functional status predicts outcomes at six months after surgery, Fortin, P.R., Clarke, A.E., Joseph, L., Liang, M.H., Tanzer, M., Ferland, D., Phillips, C., Partridge, A.J., Bélisle, P., Fossel, A.H., Mahomed, N., Sledge, C.B., Katz, J.N., Arthritis and Rheumatism, 1999, 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R
  • Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physical health, Dobkin, P.L., Da Costa, D., Dritsa, M., Fortin, P.R., Senécal, J.-L., Goulet, J.-R., Choquette, D., Rich, E., Beaulieu, A., Cividino, A., Edworthy, S., Barr, S., Ensworth, S., Esdaile, J.M., Gladman, D., Smith, D., Zummer, M., Clarke, A.E., Arthritis Care and Research, 1999, 10.1002/1529-0131(199912)12:6<401::aid-art8>3.0.co;2-f
  • Recruitment strategies in superiority trials in SLE: Lessons from the study of methotrexate in lupus erythematosus (SMILE), Ferland, D., Fortin, P.R., Lupus, 1999, 10.1191/096120399680411371
  • Responsiveness and sensitivity to change of SLE disease activity measures, Corzillius, M., Fortin, P., Stucki, G., Lupus, 1999, 10.1191/096120399680411416
  • Systemic lupus erythematosus, a disease associated with low levels of clusterin/ApoJ, an antiinflammatory protein, Newkirk, M.M., Apostolakos, P., Neville, C., Fortin, P.R., Journal of Rheumatology, 1999
  • The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, Liang, M.H., Corzillius, M., Bae, S.-C., Lew, R.A., Fortin, P.R., Gordon, C., Isenberg, D., Alarcón, G.S., Straaton, K.V., Denburg, J., Denburg, S., Esdaile, J.M., Glanz, B.I., Karlson, E.W., Khoshbin, S., Rogers, M.P., Schur, P.H., Hanly, J.G., Kozora, E., West, S., Lahita, R.G., Lockshin, M.D., McCune, J., Moore, P.M., Petri, M., Roberts, W.N., Sanchez-Guerrero, J., Veilleux, M., Brey, R., Cornblath, W.D., Filley, C.M., Fisk, J.D., Harten, P., Hay, E.M., Iverson, G., Levine, S.R., Waterhouse, E., Wallace, D.J., Winer, J.B., Arthritis and Rheumatism, 1999, 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
  • The needs of patients with arthritis: The patient's perspective, Neville, C., Fortin, P.R., Fitzcharles, M.-A., Baron, M., Abrahamowitz, M., Du Berger, R., Esdaile, J.M., Arthritis Care and Research, 1999, 10.1002/1529-0131(199904)12:2<85::aid-art3>3.0.co;2-w
  • The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus, Da Costa, D., Clarke, A.E., Dobkin, P.L., Senecal, J.-L., Fortin, P.R., Danoff, D.S., Esdaile, J.M., International Journal for Quality in Health Care, 1999, 10.1093/intqhc/11.3.201
  • The role of stress in functional disability among women with systemic lupus erythematosus: A prospective study, Da Costa, D., Dobkin, P.L., Pinard, L., Fortin, P.R., Danoff, D.S., Esdaile, J.M., Clarke, A.E., Arthritis Care and Research, 1999, 10.1002/1529-0131(199904)12:2<112::aid-art6>3.0.co;2-2
  • A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE, Ligier, S., Fortin, P.R., Newkirk, M.M., British Journal of Rheumatology, 1998
  • Comprehensive radiographic evaluation of diffuse idiopathic skeletal hyperostosis: Development and interrater reliability of a scoring system, Mata, S., Chhem, R.K., Fortin, P.R., Joseph, L., Esdaile, J.M., Seminars in Arthritis and Rheumatism, 1998, 10.1016/S0049-0172(98)80041-3
  • Impact of disease activity and cumulative damage on the health of lupus patients, Fortin, P.R., Abrahamowicz, M., Neville, C., Du Berger, R., Fraenkel, L., Clarke, A.E., Danoff, D., Lupus, 1998, 10.1191/096120398678919813
  • Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin, Rauch, J., Tannenbaum, M., Neville, C., Fortin, P.R., Thrombosis and Haemostasis, 1998, 10.1055/s-0037-1615392
  • Predictors of delay in starting radiation treatment for patients with early stage breast cancer, Benk, V., Ho, V., Fortin, P.R., Zhang, G., Levinton, C., Freeman, C.R., International Journal of Radiation Oncology Biology Physics, 1998, 10.1016/S0360-3016(98)00046-7
  • Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus, Dobkin, P.L., Fortin, P.R., Joseph, L., Esdaile, J.M., Danoff, D.S., Clarke, A.E., Arthritis and Rheumatism, 1998, 10.1002/art.1790110105
  • The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: A decision aid for development of entry criteria for clinical trials, Abrahamowicz, M., Fortin, P.R., Du Berger, R., Nayak, V., Neville, C., Liang, M.H., Journal of Rheumatology, 1998
  • A controlled study of diffuse idiopathic skeletal hyperostosis: Clinical features and functional status, Mata, S., Fortin, P.R., Fitzcharles, M.-A., Starr, M.R., Joseph, L., Watts, C.S., Gore, B., Rosenberg, E., Chhem, R.K., Esdaile, J.M., Medicine, 1997, 10.1097/00005792-199703000-00003
  • Corrigendum: Viewpoint: Response criteria for clinical trials in systemic lupus erythematosus (Lupus (1995) 4 (336-338)), Liang, M.H., Fortin, P.R., Lupus, 1997
  • Familial antiphospholipid syndrome and HLA-DRB gene associations, Hudson, N., Busque, L., Rauch, J., Kassis, J., Fortin, P.R., Arthritis and Rheumatism, 1997, 10.1002/art.1780401030
  • The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus, Gladman, D.D., Urowitz, M.B., Goldsmith, C.H., Fortin, P., Ginzler, E., Gordon, C., Hanly, J.G., Isenberg, D.A., Kalunian, K., Nived, O., Petri, M., Sanchez-Guerrero, J., Snaith, M., Sturfelt, G., Arthritis and Rheumatism, 1997, 10.1002/art.1780400506
  • Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews, Moher, D., Fortin, P., Jadad, A.R., Jüni, P., Klassen, T., Le Lorier, J., Liberati, A., Linde, K., Penna, A., Lancet, 1996, 10.1016/S0140-6736(96)90538-3
  • The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus, Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., Hay, E., Isenberg, D., Jones, J., Kalunian, K., Maddison, P., Nived, O., Petri, M., Richter, M., Sanchez-Guerrero, J., Snaith, M., Sturfelt, G., Symmons, D., Zoma, A., Arthritis and Rheumatism, 1996, 10.1002/art.1780390303
  • Vasculitides associated with malignancy, Fortin, P.R., Current Opinion in Rheumatology, 1996, 10.1097/00002281-199601000-00005
  • Measuring relevant change: an emerging challenge in rheumatologic clinical trials, Fortin, P.R., Stucki, G., Katz, J.N., Arthritis & Rheumatism, 1995, 10.1002/art.1780380802
  • Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group - A review of 45 cases, Fortin, P.R., Larson, M.G., Watters, A.K., Yeadon, C.A., Choquette, D., Esdaile, J.M., Journal of Rheumatology, 1995
  • Response criteria for clinical trials in systemic lupus erythematosus, Liang, M.H., Fortin, P.R., Lupus, 1995, 10.1177/096120339500400502
  • Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests, Fortin, P.R., Abrahamowicz, M., Danoff, D., Journal of Rheumatology, 1995
  • Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis, Fortin, P.R., Lew, R.A., Liang, M.H., Wright, E.A., Beckett, L.A., Chalmers, T.C., Sperling, R.I., Journal of Clinical Epidemiology, 1995, 10.1016/0895-4356(95)00028-3
  • A study of manufacturer-supported trials of nonsteroidal anti- inflammatory drugs in the treatment of arthritis, Rochon, P.A., Gurwitz, J.H., Simms, R.W., Fortin, P.R., Felson, D.T., Minaker, K.L., Chalmers, T.C., Archives of Internal Medicine, 1994, 10.1001/archinte.154.2.157
  • Chest radiographs as a screening test for diffuse idiopathic skeletal hyperostosis, Mata, S., Hill, R.O., Joseph, L., Kaplan, P., Dussault, R., Watts, C.S., Fitzcharles, M.-A., Shiroky, J.B., Fortin, P.R., Esdaile, J.M., Journal of Rheumatology, 1993
  • Health Insurance Coverage and Clinical Outcomes in Women with Breast Cancer, Hamilton, V., Benk, V., Fortin, P., Ayanian, J.Z., Kohler, B.A., Epstein, A.M., New England Journal of Medicine, 1993, 10.1056/NEJM199312303292716
  • Reporting of Age Data in Clinical Trials of Arthritis: Deficiencies and Solutions, Rochon, P.A., Fortin, P.R., Dear, K.B.G., Minaker, K.L., Chalmers, T.C., Archives of Internal Medicine, 1993, 10.1001/archinte.1993.00410020091008
  • Epidemiologic studies of rheumatoid arthritis: Future directions, Heath Jr., C.W., Fortin, P.R., Journal of Rheumatology, 1992
  • Quality assurance in Canada: Does insurance affect assurance?, Fortin, P.R., Journal of Rheumatology, 1992
  • Systemic lupus international collaborative clinics: Development of a damage index in systemic lupus erythematosus, Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., Hay, E., Isenberg, D., Verrier Jones, J., Nived, O., Petri, M., Richter, M., Sanchez-Guerrero, J., Snaith, M., Sturfelt, G., Symmons, D., Journal of Rheumatology, 1992
  • Fatal pulmonary venoocclusive disease secondary to a generalized venulopathy: A new syndrome presenting with facial swelling and pericardial tamponade, Liang, M.H., Stern, S., Fortin, P.R., Louie, D.C., Marsh, J.D., Mudge, G.H., Murphy, G., Arthritis & Rheumatism, 1991, 10.1002/art.1780340217
  • Management of osteoarthritis of the hip and knee, Liang, M.H., Fortin, P., New England Journal of Medicine, 1991, 10.1056/NEJM199107113250210
  • Quality assurance and audit: Lessons from North America, Liang, M.H., Fortin, P., Annals of the Rheumatic Diseases, 1991, 10.1136/ard.50.7.522
  • Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda, Liang, M.H., Fortin, P.R., Isenberg, D.A., Snaith, L., Rheumatology International, 1991, 10.1007/BF00304502
  • α1-antitrypsin deficiency and systemic necrotizing vasculitis, Fortin, P.R., Fraser, R.S., Watts, C.S., Esdaile, J.M., Journal of Rheumatology, 1991
  • Tuberculosis of the skull, Miller, M.A., Lebel, F., Fortin, P.R., American Journal of Roentgenology, 1990, 10.2214/ajr.155.5.2120959

Contribution à l'enseignement aux cycles supérieurs

Étudiant(e)s dirigé(e)s*

Depuis 2009
  • Laurence Mainville - Maitrîse avec mémoire - En cours
  • Alix St-Aubin - Maitrîse avec mémoire - En cours
*Les supervisions d’étudiant(e)s de 1er cycle en stage de recherche et de résident(e)s aux études médicales postdoctorales seront répertoriées ultérieurement.

Direction et personnes-ressources

Vice-décanat à la recherche et aux études supérieures
Pavillon Ferdinand-Vandry
Université Laval
1050, avenue de la Médecine,  local 4645
Québec, Québec G1V 0A6
Canada

Renseignements - Secrétariat :
vdres@fmed.ulaval.ca

Jacques Simard
Vice-doyen à la recherche et aux études supérieures
vice-doyen.recherche-et-etudes-superieures@fmed.ulaval.ca

Louise Laperrière
Adjointe au vice-doyen à la recherche et aux études supérieures
louise.laperriere@fmed.ulaval.ca 

Volet recherche
Gestion financière
Volet études aux cycles supérieurs